rfhg_135675.1

Basic information about the TSS

---

TSS ID: rfhg_135675.1 Species: human Chr: chr11		Start: 34052972 End: 34052972 Strand: +
Source datasets	EPD
Protocol	TSS_database
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000529307.1:9 AK127972:9 GeneID: 4076 HGNC/MGI_ID: HGNC:6743 UniProt_ID: B3KXU8 G3V153 Nearer transcript ids and distances: EU176701:-394 EU176359:-394 EU176467:-394 ENST00000526494.5:479 view more...

Gene_name: cell cycle associated protein 1 Gene_symbol: CAPRIN1 Gene_synonyms: RNG105 caprin-1 Gene_source: HGNC:6743

TATA-Box annotation

---

Distance to TSS:	1241
Nearest PromoterID:	NM_203364
Entrez ID:	4076
Nearest Unigene:	Hs.471818
Nearest Refseq:	NM_005898
Nearest Ensembl:	ENSG00000135387
Gene Name:	cell cycle associated protein 1
Gene Alias:	GPIAP1|GPIP137|GRIP137|M11S1|RNG105|p137GPI
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	1.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CAPRIN1 p2@CAPRIN1 p3@CAPRIN1 p4@CAPRIN1 p5@CAPRIN1 p6@CAPRIN1 p7@CAPRIN1 p8@CAPRIN1
Sample		p1@CAPRIN1	p2@CAPRIN1	p3@CAPRIN1	p4@CAPRIN1	p5@CAPRIN1	p6@CAPRIN1	p7@CAPRIN1	p8@CAPRIN1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	48.70	58.05	45.58	51.82	34.09	13.44	2.73	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	59.68	60.70	43.09	52.60	38.24	12.95	3.24	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	60.57	57.10	45.53	55.17	38.58	13.31	2.51	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	48.03	45.32	37.01	50.52	34.51	11.02	1.87	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	48.14	56.69	38.69	49.49	35.32	10.57	1.80	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	44.96	47.29	39.15	50.97	33.34	9.50	1.94	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	66.45	43.79	50.55	66.45	58.61	15.25	2.18	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	58.37	39.48	51.11	44.81	40.94	11.38	2.18	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	57.92	45.95	45.74	45.31	40.61	14.11	2.14	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	63.18	71.87	38.83	56.22	87.52	16.81	5.80	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	63.87	61.85	48.10	44.06	75.19	12.94	1.21	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	62.61	65.86	40.66	47.57	79.28	13.01	3.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	59.16	24.34	25.15	13.54	10.96	9.67	1.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	44.20	18.79	23.30	15.64	16.09	7.67	1.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	50.06	20.86	19.10	14.49	13.17	9.44	1.76	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	52.06	23.14	24.39	14.08	15.84	11.57	3.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	44.77	17.25	21.62	11.36	13.76	10.05	2.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	39.23	19.40	22.78	13.50	12.65	10.97	4.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	35.72	17.59	20.26	20.79	11.20	15.46	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	41.82	18.65	19.41	11.58	11.13	6.17	1.05	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	44.24	22.59	22.72	15.90	14.17	9.36	2.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	34.52	19.68	20.37	12.43	12.08	8.46	1.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	42.78	17.71	19.00	12.54	13.31	9.44	1.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	45.62	16.26	24.02	13.35	13.10	10.68	2.43	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	39.99	16.25	23.99	16.00	13.93	10.84	1.29	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	48.43	15.19	26.27	18.36	13.29	9.50	1.58	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	39.01	16.48	31.32	8.79	12.64	9.89	2.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	41.49	24.52	24.05	14.38	10.37	9.19	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	32.63	16.48	18.25	10.34	9.37	8.08	1.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	38.73	22.62	21.53	13.93	10.13	6.70	1.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	37.05	20.10	18.42	16.12	11.30	7.12	1.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	35.75	17.98	24.03	15.63	11.33	8.79	1.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	40.31	18.57	22.58	14.14	10.34	8.44	2.74	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	32.49	18.97	28.37	16.66	11.38	9.24	1.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	32.91	20.94	20.38	12.72	11.97	6.92	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	43.50	17.63	22.61	13.03	10.73	7.47	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	38.83	19.82	21.87	14.10	11.04	5.11	2.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	36.67	17.13	23.37	12.69	10.07	7.25	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	38.89	19.45	22.42	17.02	11.61	8.64	2.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	37.45	20.41	25.69	14.64	13.92	7.92	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	33.88	20.70	22.58	10.35	8.70	7.53	1.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	31.77	20.06	29.57	16.10	10.69	7.76	0.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	40.07	19.61	21.93	14.34	12.23	7.59	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	46.15	25.70	22.38	12.41	9.27	5.94	1.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	45.78	22.49	25.50	15.46	7.83	8.23	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	55.14	24.20	26.75	12.33	9.07	5.35	2.79	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	45.10	20.15	24.95	15.35	8.40	6.00	1.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	48.28	23.84	22.95	18.18	11.03	7.15	1.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	51.23	25.37	28.96	16.04	11.25	7.42	1.91	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	47.72	19.21	27.09	14.96	7.08	7.48	1.01	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	53.49	23.16	21.32	14.55	8.20	7.38	1.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	58.71	25.80	25.35	11.79	7.78	6.67	2.67	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	209.88	363.80	195.89	27.98	181.90	41.98	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	58.91	26.26	32.65	11.36	7.81	4.61	1.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	59.65	28.17	27.17	7.29	6.63	3.65	1.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	64.60	66.28	75.50	26.85	24.33	19.30	6.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	36.28	23.42	28.47	13.32	7.81	7.81	3.67	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	60.61	25.93	31.76	14.58	7.45	5.51	3.57	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	77.72	24.73	27.94	12.20	10.92	6.74	1.28	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	39.61	21.06	30.49	12.57	6.92	5.97	2.51	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	69.10	22.56	33.14	16.22	10.58	4.23	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	66.17	19.07	25.24	11.22	5.61	7.29	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	51.75	29.46	39.01	10.35	11.15	4.78	6.37	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	37.37	21.75	24.12	9.17	9.17	5.44	3.74	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	76.03	25.34	34.44	13.00	8.12	7.15	3.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	56.44	21.65	25.20	10.29	3.90	6.74	2.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	177.80	307.11	210.13	80.82	193.97	48.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	150.05	284.31	197.44	94.77	86.87	71.08	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	50.70	14.14	21.45	10.73	11.21	7.80	0.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	47.60	15.37	19.34	12.89	5.45	4.46	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	29.55	15.95	18.76	14.07	12.67	7.97	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	30.14	15.90	19.54	12.59	16.56	6.95	1.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	35.57	17.01	20.42	11.14	12.06	10.52	3.09	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	45.25	14.37	18.34	17.73	13.45	7.95	2.45	0.00
Adipocyte - breast, donor1	11376-118A8	60.34	59.71	28.03	7.76	4.59	2.69	1.74	0.00
Adipocyte - breast, donor2	11327-117E4	46.04	58.72	16.20	8.50	4.33	3.05	2.89	0.00
Adipocyte - omental, donor1	11473-119C6	66.16	73.28	21.88	9.41	5.47	2.42	0.38	0.00
Adipocyte - omental, donor2	11474-119C7	36.63	59.80	17.94	5.98	5.23	0.75	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	50.24	58.61	13.73	7.03	2.68	2.34	1.67	0.00
Adipocyte - perirenal, donor1	11476-119C9	46.57	49.13	19.78	7.02	2.55	2.55	1.91	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	18.69	23.09	11.00	3.30	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	35.23	74.07	24.84	7.23	4.97	4.06	1.35	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	45.36	62.04	6.95	4.52	2.95	1.74	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	76.66	77.64	36.96	23.08	8.61	3.91	0.98	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	66.40	42.21	29.34	13.90	11.58	7.98	0.51	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	85.30	69.14	26.20	16.17	11.43	6.69	0.56	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	83.47	91.11	31.15	19.40	12.93	8.23	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	84.54	111.56	26.30	15.20	7.40	4.02	0.56	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	63.26	69.39	32.60	13.88	12.59	10.97	0.65	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	49.05	84.24	17.60	10.66	10.66	4.80	1.60	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	70.67	80.13	15.02	8.90	8.90	2.78	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	48.66	61.97	9.98	6.24	4.99	2.91	1.25	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	45.71	57.52	16.58	9.04	5.27	3.27	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	47.12	63.81	17.02	9.16	6.54	2.95	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	46.89	51.46	11.57	8.22	4.87	4.57	0.91	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	26.74	23.20	17.90	9.50	3.54	3.09	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	14.34	8.61	5.02	4.66	1.79	1.79	0.72	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	3.59	2.40	4.79	1.20	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	41.02	42.46	11.87	6.48	5.40	2.34	0.54	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	25.10	11.71	10.04	5.02	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	35.13	26.50	8.83	4.73	4.31	1.64	0.41	0.00
Anulus Pulposus Cell, donor1	11248-116E6	73.58	45.08	22.08	13.50	13.62	8.81	0.80	0.00
Anulus Pulposus Cell, donor2	11463-119B5	62.70	42.37	19.10	10.78	5.63	5.63	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	35.94	38.64	21.57	9.44	5.39	4.04	1.35	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	33.86	41.68	20.40	9.99	6.08	3.91	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	44.95	32.10	10.70	4.28	2.14	6.42	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	37.07	46.93	14.05	10.16	5.98	2.09	3.29	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	43.00	36.67	18.97	10.12	6.32	2.53	2.53	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	31.68	25.08	15.84	5.28	3.30	0.66	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	33.79	32.81	15.59	8.45	3.25	2.60	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	39.32	46.60	19.42	7.77	4.37	3.40	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	36.82	36.82	10.10	5.34	9.50	5.94	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	33.90	39.17	20.34	6.03	3.01	3.77	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	39.19	31.20	9.43	14.51	7.26	1.45	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	28.84	30.09	13.79	3.76	5.02	0.00	2.51	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	54.53	44.15	25.04	10.21	5.93	5.27	0.66	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	40.94	35.48	24.57	13.65	13.65	0.00	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	38.90	37.25	18.70	10.56	4.37	3.62	0.75	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	43.93	35.36	16.07	8.04	4.82	1.61	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	43.64	40.43	13.98	11.71	3.59	3.59	0.57	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	44.37	42.77	22.18	12.30	4.54	2.94	0.53	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	41.94	39.02	12.68	9.75	4.88	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	38.98	41.80	13.77	7.96	4.48	3.98	0.66	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	39.62	26.42	18.01	4.80	9.61	4.80	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	63.72	35.40	28.32	21.24	14.16	10.62	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	40.82	40.14	12.01	11.32	4.63	3.26	0.86	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	50.34	46.14	8.39	0.00	0.00	0.00	8.39	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	34.47	49.03	12.62	9.22	9.22	4.37	0.97	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	40.98	40.22	15.56	7.59	6.07	3.04	0.76	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	39.98	39.98	15.75	12.11	8.48	7.27	2.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	45.03	46.74	17.67	9.12	3.42	5.70	1.71	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	38.48	41.47	12.61	7.48	3.85	4.06	1.50	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	38.20	28.65	14.71	7.23	5.94	3.87	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	35.19	41.29	15.01	9.85	5.16	3.28	1.41	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	39.55	44.70	18.01	8.68	4.82	2.25	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	38.53	32.11	15.70	8.56	4.99	2.14	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	39.19	35.68	11.70	11.11	5.26	2.34	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	41.85	37.94	21.08	9.94	5.12	3.61	0.90	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	34.45	21.38	14.26	14.26	8.32	2.38	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	41.19	41.19	14.75	9.15	4.58	6.61	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	35.66	33.36	17.57	6.88	6.62	4.84	2.04	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	33.04	24.14	10.17	6.35	3.18	2.54	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	36.25	34.09	17.26	10.36	3.45	4.32	2.16	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	39.37	36.62	12.07	8.47	5.08	3.18	1.06	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	41.18	29.29	12.47	7.25	5.22	2.90	0.58	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	32.12	44.40	15.12	7.56	7.56	2.83	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	41.53	41.70	16.44	9.15	4.07	4.07	0.68	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	44.01	46.33	9.27	6.95	2.32	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	40.14	40.14	25.35	8.45	4.23	4.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	32.81	36.88	14.15	7.72	3.86	4.93	0.64	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	41.51	27.68	16.24	11.43	3.61	4.81	2.41	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	29.16	32.07	13.12	7.29	4.37	2.19	1.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	40.00	41.61	15.40	10.11	6.21	1.84	0.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	25.50	48.46	30.60	7.65	5.10	0.00	5.10	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	41.69	43.73	22.88	11.69	7.63	4.07	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	42.94	40.67	20.44	12.80	5.78	3.51	0.83	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	41.92	30.60	16.52	10.10	6.12	3.98	1.22	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	42.07	43.98	18.64	6.69	8.60	5.26	0.96	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	40.80	32.37	16.85	12.42	3.55	3.33	1.11	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	30.52	33.57	12.21	7.63	1.53	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	28.80	38.22	18.28	13.85	3.88	4.98	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	43.96	33.10	19.59	12.18	2.65	2.12	1.32	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	38.53	27.62	16.36	5.82	6.54	1.82	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	44.09	26.28	20.63	12.90	5.90	5.65	0.12	0.00
Astrocyte - cerebellum, donor2	11580-120F5	41.42	19.85	16.09	9.93	4.96	2.57	0.34	0.00
Astrocyte - cerebellum, donor3	11661-122F5	20.14	9.44	8.39	3.78	1.68	3.15	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	93.77	51.24	56.47	33.81	36.60	17.08	1.05	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	114.70	73.77	67.30	51.77	36.40	17.47	2.91	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	95.16	57.13	57.73	43.55	34.75	17.45	0.60	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	106.89	33.95	67.21	50.46	43.92	25.80	3.33	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	120.52	41.09	78.68	55.50	44.60	31.57	2.26	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	121.42	38.92	81.02	51.21	39.94	31.07	2.39	0.00
Basophils, donor1	12241-129G9	26.15	24.32	11.77	7.32	8.63	3.40	0.00	0.00
Basophils, donor2	12242-129H1	42.57	51.95	24.89	12.27	22.37	6.49	0.36	0.00
Basophils, donor3	12243-129H2	36.75	26.46	9.41	9.85	14.55	5.29	0.88	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	11.00	10.56	5.61	3.67	4.10	2.16	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	8.23	3.66	2.29	1.83	1.37	0.91	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	50.21	71.74	28.69	14.35	0.00	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	45.82	19.46	25.73	26.36	10.04	8.79	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	40.34	26.20	29.53	22.67	10.40	5.20	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	33.85	18.88	10.82	14.51	8.98	5.53	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	27.71	34.73	16.91	12.42	14.04	5.94	1.98	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	105.32	56.68	57.09	20.30	37.31	9.27	0.82	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	99.22	47.28	111.79	41.92	37.03	15.14	1.86	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	62.36	64.91	59.16	31.66	73.23	19.51	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	113.76	62.05	72.39	31.03	72.39	20.68	10.34	0.00
CD14+ Monocytes, donor1	11224-116B9	32.12	29.30	11.83	9.02	12.40	6.20	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	36.56	27.84	12.25	10.76	20.42	4.83	0.19	0.00
CD14+ Monocytes, donor3	11381-118B4	32.71	34.03	12.29	8.12	13.39	3.29	0.66	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	82.37	40.76	17.55	9.91	7.93	5.38	0.28	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	86.43	45.87	24.64	7.58	10.99	6.82	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	100.59	42.41	25.97	14.14	14.46	12.49	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	35.56	28.62	16.33	8.67	10.55	4.19	1.45	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	40.43	27.76	22.33	10.26	14.79	6.34	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	49.27	34.35	20.14	13.03	14.69	6.16	0.47	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	21.09	17.58	9.71	8.20	11.72	3.18	0.17	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	25.39	23.74	17.94	7.73	8.56	2.76	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	18.10	20.58	27.52	9.42	15.12	5.21	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	15.27	12.92	8.42	4.70	7.24	2.94	0.39	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	23.32	17.09	8.90	6.94	11.04	2.49	0.36	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	17.19	23.50	18.93	7.18	12.84	3.92	0.44	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	20.13	11.94	8.66	4.21	11.00	3.04	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	27.46	27.99	13.20	10.56	15.31	6.34	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	21.08	29.95	13.31	5.55	16.64	4.44	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	24.99	16.21	13.68	9.97	10.26	4.02	0.89	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	21.55	22.15	24.15	8.38	7.98	2.99	0.80	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	17.91	26.23	29.77	10.83	12.08	3.75	0.21	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	14.87	14.64	9.15	4.12	9.38	3.20	0.69	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	20.13	22.17	16.97	5.88	10.86	3.39	0.45	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	17.46	16.15	10.04	4.36	9.60	3.06	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	27.44	25.55	10.49	11.30	15.06	4.03	0.54	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	32.45	25.30	14.48	9.94	12.74	4.19	0.70	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	38.72	34.93	23.15	8.00	20.20	6.73	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	10.29	11.76	7.72	4.96	5.33	2.20	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	17.97	18.67	19.37	8.81	10.57	2.11	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	14.92	10.97	14.04	11.85	10.97	6.58	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	19.01	15.52	8.72	7.15	9.76	3.14	0.17	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	23.79	21.56	11.15	9.29	6.69	4.09	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	23.49	27.59	20.48	7.33	14.44	4.31	0.22	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	13.10	18.84	6.14	7.37	6.96	1.23	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	16.46	21.33	13.68	5.10	8.11	3.25	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	15.78	12.76	14.85	6.73	6.73	3.02	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	45.34	36.62	18.09	11.77	15.04	8.72	0.87	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	46.66	35.80	11.32	13.63	17.32	10.39	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	43.76	28.38	13.65	9.31	13.65	7.15	0.43	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	74.75	47.18	17.91	14.33	18.53	8.25	0.16	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	62.35	40.34	16.24	12.23	22.01	6.81	0.17	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	97.66	67.78	26.76	14.72	25.86	11.82	0.89	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	45.68	35.47	10.21	9.70	10.72	5.87	0.51	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	52.48	38.42	14.27	8.56	15.15	5.93	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	49.90	41.69	13.90	9.05	11.16	6.11	0.42	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	32.52	16.26	46.74	14.23	18.29	10.16	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	51.53	21.70	47.46	25.09	8.81	11.53	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	48.67	21.75	52.82	13.46	10.36	11.39	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	57.57	44.24	37.31	12.79	9.59	8.00	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	71.30	35.92	46.64	14.47	8.58	13.40	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	49.84	25.97	50.54	16.85	9.83	9.83	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	36.08	19.61	35.30	13.33	7.06	6.27	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	58.00	30.32	36.91	13.18	9.23	14.50	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	46.85	37.81	54.25	36.99	11.51	12.33	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	26.84	32.64	33.37	18.86	15.96	8.71	1.45	0.00
CD19+ B Cells, donor3	11705-123B4	31.80	28.27	45.43	25.75	14.14	9.59	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	90.91	94.95	27.07	22.63	16.16	15.35	1.21	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	74.70	58.33	22.37	19.18	11.19	7.99	1.20	0.00
CD34+ Progenitors, donor1	11545-120B6	62.25	64.26	36.15	14.06	35.14	9.04	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	42.14	46.07	32.58	26.97	34.27	16.85	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	75.15	60.12	58.24	32.31	38.33	14.28	0.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	85.23	60.66	66.97	29.99	57.05	20.97	0.45	0.00
CD4+ T Cells, donor1	11225-116C1	49.63	53.92	53.56	15.71	14.28	5.71	0.71	0.00
CD4+ T Cells, donor2	11306-117C1	41.03	50.21	39.19	14.70	13.47	6.74	1.84	0.00
CD4+ T Cells, donor3	11382-118B5	43.92	49.41	49.10	17.69	9.15	6.40	0.30	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	65.09	38.54	59.73	19.91	10.21	12.51	0.51	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	59.74	34.81	70.97	23.81	12.13	15.27	0.22	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	66.12	32.48	71.58	23.86	9.77	14.66	0.86	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	43.62	43.62	52.62	17.07	10.43	8.06	0.95	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	39.33	35.12	52.67	16.86	3.51	9.13	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	39.55	39.55	62.63	6.59	13.18	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	64.45	35.12	42.34	16.04	7.95	7.66	0.43	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	70.84	28.64	53.21	18.47	8.30	7.80	0.68	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	61.58	24.34	52.71	19.18	7.09	7.09	0.64	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	32.73	34.97	40.35	13.00	7.17	9.41	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	44.37	36.69	46.47	16.07	7.69	8.73	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	55.88	48.40	69.96	19.36	7.92	10.56	0.88	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	71.26	54.81	61.14	18.13	10.96	15.60	2.11	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	65.45	32.83	41.55	16.83	10.80	8.31	1.25	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	71.50	30.74	38.42	12.03	9.69	7.02	0.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	48.13	32.90	63.09	15.77	6.80	10.33	1.09	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	63.24	58.95	84.14	29.48	10.18	13.93	1.07	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	60.97	53.80	86.07	17.93	8.97	8.97	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	83.07	52.66	51.36	19.10	12.98	13.35	1.11	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	61.09	40.51	49.82	16.68	8.23	8.01	0.65	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	72.29	47.91	46.23	15.34	10.09	6.94	0.42	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	29.83	32.86	46.52	15.67	8.09	6.57	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	33.36	34.23	45.49	17.33	9.10	8.67	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	47.50	48.38	69.29	20.48	10.90	9.59	1.31	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	82.15	48.50	96.00	24.25	10.89	18.81	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	46.16	33.23	79.39	22.16	9.23	12.00	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	44.67	40.48	71.19	26.52	4.19	11.17	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	89.17	70.89	71.72	24.92	12.18	11.35	0.28	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	93.49	65.03	92.51	31.16	15.71	13.99	0.49	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	95.48	69.30	98.56	33.88	15.40	13.86	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	68.76	45.48	83.44	18.26	13.61	10.74	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	66.48	63.71	76.17	20.77	6.92	11.08	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	32.74	51.73	43.54	17.02	9.17	8.18	0.98	0.00
CD8+ T Cells, donor2	11307-117C2	25.15	49.93	35.29	10.14	7.88	4.51	1.50	0.00
CD8+ T Cells, donor3	11383-118B6	44.94	56.31	48.23	18.68	11.87	8.33	0.25	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	21.33	14.45	36.93	23.17	7.57	8.49	1.38	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	20.13	16.30	40.02	23.01	9.59	10.54	0.72	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	22.98	17.24	35.84	25.17	7.39	8.75	0.27	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	23.12	20.11	41.13	26.12	11.71	8.41	0.60	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	18.96	17.28	36.24	20.16	8.40	8.40	1.44	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	20.46	16.60	37.97	26.38	12.05	11.14	0.68	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	29.77	20.42	44.33	29.33	11.52	10.86	0.87	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	22.11	22.64	50.54	30.79	8.95	14.74	1.05	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	30.25	23.92	49.95	25.09	9.85	15.71	1.17	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	32.00	18.72	41.96	25.96	14.79	14.19	0.91	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	24.40	15.98	34.28	26.44	10.17	11.62	1.16	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	29.31	18.65	46.36	27.44	11.99	11.46	0.53	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	23.64	18.39	28.89	21.01	17.51	9.63	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	26.41	17.31	35.07	21.41	15.48	6.38	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	29.09	15.66	46.24	20.14	14.17	4.48	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	24.85	20.53	40.34	22.33	13.69	5.76	2.52	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	17.26	14.39	31.94	22.44	8.06	7.48	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	21.68	15.79	33.47	24.04	9.66	8.49	0.94	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	24.08	25.67	58.94	32.32	14.89	10.77	0.63	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	21.53	23.37	49.21	30.14	13.23	11.99	0.92	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	24.68	21.48	48.09	28.21	10.90	11.22	0.64	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	26.01	20.65	37.10	26.39	9.94	12.62	1.15	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	23.25	17.73	35.08	21.28	8.67	8.67	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	31.77	16.64	46.14	29.50	12.86	12.10	2.27	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	36.94	34.53	50.59	24.89	13.65	12.85	1.61	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	39.17	30.08	32.87	30.08	17.49	11.89	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	33.06	32.06	45.08	33.06	16.03	14.02	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	109.66	124.29	31.07	21.93	9.14	5.48	3.66	0.00
Cardiac Myocyte, donor2	11605-120I3	38.54	40.02	28.16	11.86	20.26	6.92	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	42.51	37.04	23.68	12.52	10.84	7.05	0.21	0.00
Chondrocyte - de diff, donor1	11261-116G1	61.01	62.40	28.77	12.13	7.97	4.85	1.04	0.00
Chondrocyte - de diff, donor2	11338-117F6	44.78	59.70	25.23	5.69	6.40	4.26	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	53.25	50.40	15.59	7.62	4.10	3.53	0.80	0.00
Chondrocyte - re diff, donor2	11339-117F7	106.54	106.54	56.40	25.96	20.59	12.53	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	59.04	29.93	23.05	7.68	6.87	2.43	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	96.51	56.35	41.54	40.05	31.21	17.67	1.26	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	68.19	47.03	42.54	29.71	18.60	12.83	1.71	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	83.63	51.68	43.19	30.09	20.89	9.82	0.88	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	128.93	44.84	19.26	35.40	13.48	14.21	1.01	3.39
Corneal Epithelial Cells, donor1	11526-119I5	10.32	6.37	3.73	3.07	1.98	2.42	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	19.34	14.79	6.83	2.28	3.41	2.28	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	21.73	15.34	7.67	6.65	4.60	4.09	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	78.42	72.97	28.89	29.88	18.66	16.84	0.17	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	73.17	71.60	29.02	24.92	20.50	12.30	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	48.31	69.01	31.06	27.61	24.15	10.35	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	59.93	49.35	20.09	20.73	15.77	11.88	0.97	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	64.23	80.29	30.06	22.21	13.32	10.59	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	57.45	89.44	33.30	22.85	17.63	7.83	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	53.72	128.73	37.75	32.91	15.49	6.29	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	55.03	50.36	35.19	31.02	14.18	12.67	0.67	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	42.83	31.69	32.27	20.54	11.15	8.80	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	52.88	50.90	33.94	23.47	13.86	12.16	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	69.99	55.05	44.43	33.81	13.76	11.40	1.18	0.00
Endothelial Cells - Artery, donor1	11264-116G4	26.47	30.54	19.78	15.42	6.11	5.53	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	44.23	42.59	34.35	29.65	14.59	12.23	1.41	0.00
Endothelial Cells - Artery, donor3	11413-118E9	64.16	48.74	44.70	35.41	15.95	9.99	0.88	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	56.30	45.44	32.58	22.61	9.97	4.88	0.44	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	60.24	60.55	41.68	27.99	9.74	5.78	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	77.81	58.92	42.00	26.22	12.12	8.74	1.97	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	41.90	36.25	21.39	12.48	8.62	5.65	0.59	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	35.41	36.97	29.68	19.26	9.37	6.25	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	43.24	26.80	11.06	11.06	6.66	4.54	0.57	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	61.62	66.82	50.01	40.81	16.00	12.80	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	28.83	33.02	22.54	15.20	6.29	2.10	1.05	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	88.59	60.38	61.00	53.55	42.12	24.10	1.99	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	71.48	46.06	32.59	28.03	41.71	14.99	0.43	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	79.14	53.98	43.36	44.21	43.36	19.66	0.61	0.00
Endothelial Cells - Vein, donor1	11267-116G7	54.60	43.23	18.20	19.34	17.06	6.83	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	44.70	41.91	41.21	27.94	10.48	4.19	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	57.78	39.41	32.19	28.73	12.87	7.69	0.16	0.00
Eosinophils, donor1	12244-129H3	30.49	60.99	45.74	15.25	45.74	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	59.41	85.81	31.35	9.90	29.70	11.55	0.00	0.00
Eosinophils, donor3	12246-129H5	42.80	57.07	21.40	7.13	10.70	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	9.28	7.82	5.62	1.47	2.20	2.69	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	12.48	8.32	4.16	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	32.54	16.27	0.00	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	55.83	52.96	16.83	5.75	4.52	3.28	1.23	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	20.47	27.48	9.31	6.13	2.41	1.86	1.75	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	43.77	38.35	13.98	9.64	5.63	2.71	2.93	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	63.67	62.22	24.13	17.34	11.16	5.34	0.85	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	73.42	100.99	47.63	24.84	9.01	4.78	0.41	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	50.94	47.25	19.51	10.65	5.59	2.64	1.48	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	81.95	84.05	43.21	15.55	9.75	6.59	1.58	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	70.76	63.78	27.90	15.61	7.64	6.31	0.66	0.00
Fibroblast - Cardiac, donor1	11268-116G8	48.54	57.16	29.94	19.96	5.44	7.71	2.27	0.00
Fibroblast - Cardiac, donor2	11345-117G4	49.27	61.39	37.90	14.40	6.82	5.31	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	25.87	29.97	12.14	6.47	2.68	1.89	0.47	0.00
Fibroblast - Cardiac, donor4	11452-119A3	93.96	100.33	34.86	23.04	15.76	8.18	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	70.30	52.16	25.51	23.22	10.91	8.12	0.89	0.00
Fibroblast - Cardiac, donor6	11460-119B2	65.79	50.63	30.77	25.92	13.95	8.49	0.61	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	51.05	51.18	18.89	9.65	2.95	4.15	0.27	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	62.13	58.24	23.30	12.51	11.22	4.75	1.73	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	52.73	43.94	33.69	17.58	23.44	20.51	5.86	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	28.37	20.76	16.61	7.84	7.15	4.15	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	63.94	58.85	28.83	13.40	12.21	8.99	1.19	0.00
Fibroblast - Dermal, donor1	11269-116G9	41.79	49.07	21.37	17.14	6.81	4.70	0.70	0.00
Fibroblast - Dermal, donor2	11346-117G5	69.34	63.20	36.79	29.24	12.26	12.74	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	39.89	34.21	29.25	17.89	8.22	7.13	1.21	0.00
Fibroblast - Dermal, donor4	11450-119A1	77.10	38.10	33.46	32.67	26.11	18.77	0.90	0.00
Fibroblast - Dermal, donor5	11454-119A5	89.32	43.96	50.77	46.06	30.88	20.24	0.35	0.00
Fibroblast - Dermal, donor6	11458-119A9	88.68	53.27	56.20	41.58	28.42	22.25	1.14	0.00
Fibroblast - Gingival, donor1	11237-116D4	94.54	69.34	35.19	22.49	10.41	8.54	0.83	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	100.61	79.39	28.30	14.41	11.00	3.93	1.05	0.00
Fibroblast - Gingival, donor2	11318-117D4	74.33	46.12	38.48	29.65	20.03	12.52	3.16	0.00
Fibroblast - Gingival, donor3	11394-118C8	96.88	68.36	23.30	16.53	12.96	7.83	0.87	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	75.84	55.06	23.89	13.51	8.31	9.35	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	68.54	56.91	17.62	11.10	6.17	3.70	3.35	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	115.99	92.76	36.32	24.63	23.38	14.19	1.25	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	94.52	76.27	36.78	25.29	12.04	9.60	2.70	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	108.33	71.99	20.82	13.06	3.88	3.88	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	105.59	83.07	32.17	24.28	11.41	6.29	0.88	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	108.81	89.86	34.91	25.63	12.95	7.77	1.77	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	113.75	90.28	41.46	37.41	27.75	10.20	1.32	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	99.64	75.42	33.16	12.91	10.27	4.84	1.17	0.00
Fibroblast - Lung, donor1	11270-116H1	29.91	27.19	24.47	13.59	13.59	6.80	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	68.64	64.16	34.32	31.34	16.41	7.46	2.98	0.00
Fibroblast - Lung, donor3	11419-118F6	51.91	30.81	29.33	22.58	14.56	11.61	1.27	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	39.15	46.65	14.99	7.50	2.50	4.17	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	30.77	25.18	12.59	11.19	2.80	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	8.12	7.00	4.48	1.40	1.12	0.28	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	58.87	50.34	27.20	8.93	6.90	8.12	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	27.96	19.97	7.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	47.65	23.83	0.00	0.00	11.91	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	88.26	54.31	39.76	36.66	29.48	16.10	0.39	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	117.10	64.46	46.72	42.32	36.40	22.75	2.58	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	119.95	110.46	52.94	31.52	18.36	17.14	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	75.94	76.32	22.90	9.54	14.12	5.34	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	66.42	63.72	15.66	11.88	7.02	3.78	0.81	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	75.50	59.26	21.46	8.70	4.64	2.90	0.35	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	46.20	41.34	30.84	17.91	11.83	7.41	0.44	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	41.45	39.01	16.26	10.16	5.08	3.86	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	17.37	17.37	12.03	6.68	6.68	3.34	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	34.00	29.26	20.56	13.84	16.21	9.09	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	124.63	132.56	60.33	24.81	13.49	10.91	2.38	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	53.29	62.34	22.38	9.41	4.26	4.09	1.07	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	64.25	69.57	32.32	17.93	10.25	6.70	0.59	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	100.79	98.08	53.55	23.77	10.23	8.42	1.50	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	62.07	79.67	29.69	18.68	9.82	6.91	1.62	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	106.04	113.63	40.49	15.44	4.56	6.83	2.28	0.00
Fibroblast - skin normal, donor1	11553-120C5	67.93	65.47	20.18	8.86	4.59	3.94	1.80	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	111.48	111.08	61.96	26.07	10.23	7.02	0.80	0.00
Fibroblast - skin normal, donor2	11561-120D4	77.26	84.49	24.01	15.47	8.34	4.52	1.51	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	139.33	117.57	74.95	31.73	17.23	12.09	1.51	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	59.81	57.74	32.64	16.07	9.28	5.63	0.41	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	74.53	85.48	32.14	16.24	7.35	7.01	1.20	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	110.35	111.67	44.34	19.05	8.87	9.20	0.99	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	62.42	79.57	26.74	18.53	10.23	6.71	0.64	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	75.23	79.11	34.92	16.19	9.61	7.42	0.67	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	37.32	35.13	13.02	8.00	4.08	2.51	1.73	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	421.04	620.47	265.92	132.96	110.80	44.32	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	63.62	84.54	28.76	21.79	20.92	10.46	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	53.57	55.30	33.63	27.74	13.35	7.28	0.69	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	57.77	39.56	30.19	26.28	8.07	7.03	0.78	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	67.71	55.19	37.05	33.98	16.61	9.45	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	69.67	42.11	76.56	68.13	38.28	18.37	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	69.55	37.65	91.88	81.67	39.56	19.14	1.91	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	64.47	43.07	84.72	57.34	21.11	13.69	1.71	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	100.10	48.81	68.94	70.87	36.12	14.62	1.93	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	94.53	42.24	49.78	52.97	38.13	17.58	1.83	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	69.15	40.02	62.41	51.91	23.78	9.11	1.78	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	85.64	38.86	62.65	54.45	39.91	15.33	1.59	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	115.78	50.23	51.86	54.79	49.25	14.35	0.33	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	59.26	41.13	80.48	57.05	19.02	9.29	1.33	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	59.92	39.57	74.76	71.09	27.28	13.28	1.98	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	62.31	54.31	46.42	61.20	32.76	12.19	1.35	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	54.80	35.19	62.32	51.31	20.15	13.16	1.07	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	50.92	36.80	45.72	48.19	24.16	8.80	1.61	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	51.08	30.45	47.90	50.39	20.07	9.55	1.25	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	43.30	22.36	50.22	33.34	14.03	10.17	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	60.01	40.39	34.45	31.72	19.62	10.72	0.68	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	51.32	37.37	42.60	46.34	19.18	7.97	1.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	59.89	29.07	36.94	30.82	16.61	8.31	1.75	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	54.07	45.21	27.48	30.73	32.21	10.05	1.18	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	62.31	50.55	40.85	49.59	25.91	8.11	1.27	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	54.51	35.08	39.10	30.61	18.32	8.71	0.45	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	69.56	47.38	37.50	38.11	36.09	15.73	3.02	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	68.03	57.51	38.17	55.30	28.50	8.65	2.37	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	84.77	52.23	58.08	50.19	30.24	14.81	0.89	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	85.43	51.20	38.29	56.92	53.90	23.00	1.25	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	77.53	61.99	47.48	41.16	45.43	19.30	0.51	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	65.40	48.47	36.96	51.23	31.20	11.95	1.33	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	78.29	47.51	47.09	48.34	29.70	13.56	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	66.56	67.79	51.45	38.18	30.83	15.11	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	66.22	41.05	31.56	31.56	37.34	14.24	1.44	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	64.79	49.11	37.47	52.00	35.05	12.22	1.50	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	64.20	43.19	28.68	33.19	31.85	9.17	1.50	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	64.15	41.44	21.60	29.76	32.84	13.23	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	57.44	50.30	28.17	43.17	35.91	11.44	2.09	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	62.41	39.87	33.88	26.91	26.26	11.18	0.49	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	59.65	42.98	31.75	38.49	53.24	17.00	3.21	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	57.04	43.97	29.09	40.84	30.98	11.28	1.14	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	58.84	32.90	23.25	26.89	29.58	13.29	1.11	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	49.87	45.00	28.89	28.89	42.27	10.95	0.91	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	51.75	46.10	24.78	33.87	24.15	8.05	1.36	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	56.21	34.03	21.08	25.47	28.76	14.93	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	63.97	46.57	26.93	28.34	30.30	13.47	1.68	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	68.51	62.77	24.72	38.70	21.20	7.41	0.83	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	52.41	38.24	21.93	23.80	24.07	10.43	1.07	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	64.11	57.68	25.55	28.00	26.93	11.02	0.31	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	52.07	49.09	22.67	28.63	18.78	7.64	1.17	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	68.31	46.08	17.35	23.31	26.29	7.32	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	62.50	55.31	23.04	24.15	17.51	7.56	0.55	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	58.56	52.85	26.54	19.52	19.52	11.18	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	121.98	82.31	31.74	12.89	35.70	5.95	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	60.55	60.02	25.20	19.13	17.68	7.26	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	52.26	52.26	22.19	17.35	12.71	8.47	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	105.73	69.13	25.16	28.47	42.44	16.27	0.51	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	73.25	56.33	114.66	98.14	29.66	17.92	1.59	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	55.62	48.07	81.66	76.73	19.57	11.86	1.23	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	88.58	61.99	109.45	118.66	37.23	18.41	0.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	54.45	35.67	76.67	63.84	25.35	13.46	1.88	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	52.56	28.26	67.53	59.90	24.86	12.43	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	74.25	46.58	103.77	86.71	29.98	19.37	1.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	74.24	56.92	56.92	47.02	24.75	7.42	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	75.04	49.90	61.12	64.98	23.21	11.60	2.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	80.22	54.55	64.18	54.55	24.07	9.63	3.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	64.34	46.95	43.47	43.47	29.56	10.43	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	70.30	57.28	41.99	49.80	27.01	7.49	4.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	72.07	54.77	61.36	53.12	24.71	15.65	2.88	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	79.97	69.98	33.32	63.31	33.32	6.66	23.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	73.27	62.36	43.35	46.70	22.37	12.86	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	77.14	51.97	51.97	48.05	23.53	8.17	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	71.30	49.49	42.78	32.71	31.88	9.23	4.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	90.33	68.07	55.66	42.94	27.67	11.45	0.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	79.82	52.31	44.16	40.42	24.12	9.17	2.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	93.97	58.47	58.47	50.12	29.23	14.62	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	77.89	59.56	63.00	51.54	38.37	22.34	4.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	67.48	36.11	36.41	35.22	22.79	11.25	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	79.62	57.60	40.66	33.88	30.49	18.64	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	95.68	72.90	51.36	49.70	28.99	11.60	4.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	94.58	70.19	61.21	49.02	33.83	14.73	3.45	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	47.42	79.03	47.42	21.07	26.34	5.27	10.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	65.35	56.12	51.13	44.59	31.52	16.91	2.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	74.97	46.94	46.61	36.51	24.45	14.34	2.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	64.88	31.44	39.46	35.45	26.08	11.37	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	77.05	47.77	53.94	44.69	47.00	10.79	2.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	76.68	105.78	67.78	53.75	43.82	15.41	1.37	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	84.48	29.82	44.73	49.70	29.82	7.45	7.45	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	76.91	43.88	39.64	55.68	58.04	19.82	2.83	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	70.01	53.11	48.88	45.87	40.43	21.12	4.83	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	70.71	49.34	46.80	54.43	54.94	14.24	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	69.40	44.67	58.23	47.46	53.84	15.95	3.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	66.11	42.92	52.30	55.26	53.78	17.27	1.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	67.29	33.05	57.84	50.76	50.76	9.44	2.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	74.68	44.34	47.26	52.51	54.26	9.92	4.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	68.90	49.15	39.94	49.59	54.42	13.61	2.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	57.64	48.32	39.84	38.15	44.08	11.02	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	56.11	51.33	40.59	30.44	25.07	5.97	1.79	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	63.08	59.20	41.25	33.97	31.06	10.19	1.94	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	50.22	57.07	22.83	10.27	2.28	4.57	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	55.30	50.73	16.63	7.90	1.66	1.66	2.08	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	74.21	55.10	24.74	12.37	3.37	7.87	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	46.62	45.99	17.13	7.93	7.29	5.07	0.95	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	27.99	35.09	6.68	6.27	7.10	1.67	1.25	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	57.21	56.74	37.25	28.55	8.70	5.69	1.28	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	64.48	82.21	52.83	34.77	11.14	6.25	1.52	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	59.38	80.99	53.24	32.99	10.01	6.60	1.14	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	56.18	55.42	38.37	29.84	8.74	6.34	2.19	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	69.63	68.34	49.21	33.10	8.81	7.52	1.29	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	64.37	67.17	54.47	32.29	10.76	9.69	1.72	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	47.20	58.53	36.12	25.78	7.72	5.36	1.37	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	58.16	71.36	45.63	28.48	7.03	6.35	1.20	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	48.70	67.92	43.25	24.99	8.33	8.01	1.28	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	41.41	25.74	17.91	10.63	8.39	3.36	1.68	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	17.31	10.39	7.36	3.90	2.60	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	55.52	47.59	26.44	10.58	18.51	5.29	5.29	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	35.98	19.40	15.17	6.35	2.82	2.47	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	24.70	13.80	7.99	2.91	1.45	2.18	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	49.83	38.29	25.18	18.36	18.18	7.34	2.27	0.00
Hepatocyte, donor1	11523-119I2	42.37	41.16	6.05	10.90	2.42	4.84	2.42	0.00
Hepatocyte, donor2	11603-120I1	34.47	31.24	33.40	19.39	3.23	7.54	1.08	0.00
Hepatocyte, donor3	11684-122I1	45.40	37.43	16.57	11.04	6.14	6.75	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	107.04	84.85	93.99	46.99	10.44	7.83	1.96	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	61.17	77.08	72.01	52.43	16.43	10.14	1.57	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	41.44	26.48	39.79	21.13	10.56	7.96	0.41	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	70.05	22.29	22.29	19.10	9.55	6.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	40.05	6.68	0.00	6.68	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	27.08	0.00	54.17	27.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	41.53	40.15	22.15	13.84	11.08	4.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	47.55	22.52	22.52	7.51	12.51	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	0.00	11.87	0.00	47.47	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	87.14	69.20	23.07	17.94	2.56	10.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	9.14	4.57	0.00	4.57	13.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	55.23	30.86	14.62	25.99	19.49	6.50	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	61.69	26.68	26.68	11.67	13.34	6.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	61.72	39.94	25.41	10.89	14.52	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	64.85	43.67	27.79	15.88	13.23	3.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	38.80	22.17	26.61	21.06	19.96	0.00	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	31.43	36.67	10.48	10.48	10.48	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	45.35	25.82	19.53	24.56	9.45	7.56	1.26	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	44.85	34.03	24.75	18.56	7.73	3.09	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	14.63	14.63	0.00	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	53.62	40.70	25.20	23.90	14.21	4.52	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	74.06	40.25	32.20	11.27	9.66	3.22	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	107.53	11.95	35.84	23.90	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	58.67	44.00	22.00	16.30	8.15	4.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	51.64	24.35	24.35	12.59	8.40	2.94	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	100.61	43.12	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	32.95	25.72	21.70	17.68	8.04	2.41	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	47.09	24.01	24.93	15.70	9.23	4.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	120.65	60.32	0.00	0.00	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	33.04	23.60	23.60	22.19	8.50	6.14	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	34.47	37.19	23.58	17.23	9.07	2.72	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	147.42	14.74	44.23	29.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	49.50	29.06	39.82	16.14	5.38	2.15	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	68.61	26.68	30.49	15.25	5.08	2.54	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	49.29	49.29	16.43	0.00	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	47.19	31.88	31.88	22.96	8.29	3.19	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	45.57	36.45	34.63	16.40	9.11	3.65	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	110.63	15.80	31.61	15.80	15.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	39.99	26.42	29.99	18.57	5.71	2.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	56.41	49.77	23.23	16.59	23.23	9.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	104.24	83.39	83.39	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	41.05	23.46	29.94	18.52	6.79	3.70	2.16	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	61.46	22.83	36.88	17.56	12.29	3.51	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	53.43	37.72	25.15	18.86	12.57	9.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	47.98	33.38	27.12	25.03	7.65	4.17	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	70.82	13.28	8.85	8.85	4.43	4.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	51.87	29.18	25.94	9.73	16.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	46.21	13.95	18.31	19.18	9.59	2.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	51.75	9.00	15.75	11.25	4.50	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	52.27	10.45	6.97	10.45	13.94	6.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	39.47	19.20	13.87	13.87	7.47	4.27	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	51.26	15.24	18.01	11.08	6.93	4.16	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	71.24	39.89	37.04	19.95	11.40	5.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	52.46	14.73	12.89	16.57	7.36	2.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	45.38	6.05	12.10	0.00	0.00	3.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	62.09	31.04	12.42	24.83	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	51.81	12.69	21.15	11.63	3.17	4.23	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	47.49	40.64	29.05	18.44	7.43	5.06	0.41	0.00
Keratinocyte - epidermal, donor2	11349-117G8	21.08	13.47	8.78	10.54	7.61	6.44	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	44.11	32.75	20.16	23.66	16.19	9.84	1.14	0.00
Keratinocyte - oral, donor1	11251-116E9	59.26	42.91	34.17	33.03	43.70	19.30	1.14	0.00
Keratocytes, donor1	11527-119I6	23.04	12.03	15.47	9.28	6.53	5.16	0.34	0.00
Keratocytes, donor2	11607-120I5	24.61	15.23	15.23	1.17	0.00	2.34	0.00	0.00
Keratocytes, donor3	11688-122I5	48.61	32.01	20.15	17.98	10.67	5.93	0.79	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	30.77	59.34	15.39	8.79	4.40	4.40	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	42.07	30.20	37.76	19.42	10.79	6.47	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	64.36	44.75	29.06	27.68	23.87	13.61	0.58	0.00
Lens Epithelial Cells, donor3	11690-122I7	71.14	66.50	52.07	23.71	8.98	5.95	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	42.69	28.22	21.70	20.51	12.33	8.77	0.83	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	32.93	16.47	16.19	17.58	14.23	5.86	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	50.21	30.85	29.59	23.93	14.01	12.12	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	23.66	21.51	15.59	11.29	10.75	9.68	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	29.63	19.23	13.55	15.13	9.45	6.62	1.89	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	25.98	18.44	14.02	12.29	7.01	6.47	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	32.01	32.42	19.29	17.65	11.90	8.21	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	18.96	9.35	11.12	7.84	5.31	3.54	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	26.46	18.72	13.23	12.53	10.84	6.76	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	30.06	25.71	16.22	15.43	13.05	8.70	1.58	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	30.63	18.03	16.29	18.23	11.63	8.34	0.58	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	17.77	9.81	7.41	7.78	3.89	2.22	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	42.51	29.96	15.33	18.47	10.45	8.01	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	32.68	19.32	18.13	17.17	10.02	7.63	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	23.07	16.34	12.91	12.50	9.61	6.18	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	32.03	23.71	20.33	20.63	11.39	10.47	0.92	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	18.70	12.47	11.85	8.11	7.17	5.92	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	26.17	16.10	16.84	13.72	9.52	6.95	0.91	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	31.92	21.72	22.38	15.47	6.91	8.89	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	25.48	13.18	12.30	10.54	7.32	4.39	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	21.16	11.95	11.20	11.45	7.22	4.98	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	32.98	30.55	23.76	21.34	9.70	12.12	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	29.35	20.47	14.54	19.39	9.96	9.16	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	29.82	20.89	17.11	17.41	12.41	8.33	0.76	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	27.99	23.33	11.41	18.14	9.85	7.26	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	34.97	22.61	20.94	20.94	10.89	9.84	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	22.56	19.40	12.18	15.04	10.23	8.72	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	26.14	19.26	19.26	18.57	15.82	8.94	1.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	25.96	19.76	15.05	16.18	11.10	6.77	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	20.99	15.90	11.56	13.04	8.91	6.15	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	28.11	24.71	17.44	18.41	11.63	9.21	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	22.82	16.54	13.23	13.56	15.55	6.62	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	21.93	15.36	12.39	11.77	6.81	6.44	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	38.87	33.32	32.58	22.21	9.26	12.59	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	27.67	16.55	16.31	16.06	9.64	11.12	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	20.62	12.65	10.86	11.55	6.32	5.77	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	38.92	28.95	25.09	22.84	12.87	11.58	0.96	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	42.30	17.65	18.87	24.35	13.09	12.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	35.27	22.25	18.48	19.46	11.34	9.38	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	35.20	24.89	20.62	16.00	10.31	9.60	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	24.24	13.09	16.00	13.57	10.18	3.39	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	17.43	10.58	10.11	10.11	5.29	4.20	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	29.36	20.05	18.62	16.83	11.82	11.10	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	28.42	16.99	16.66	21.56	9.15	6.53	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	17.19	12.01	7.06	7.53	5.41	4.24	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	40.96	30.07	32.92	18.56	11.63	11.88	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	18.19	14.34	9.73	11.01	4.87	4.10	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	21.18	15.81	13.43	14.02	6.56	7.16	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	40.79	54.38	43.05	18.13	9.06	9.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	46.03	46.03	32.99	12.27	6.90	6.14	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	37.85	41.56	17.07	19.30	5.94	5.94	2.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	42.74	41.04	28.35	21.58	7.19	4.65	1.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	39.39	41.50	16.18	10.55	6.33	2.81	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	38.29	45.76	22.42	11.21	5.60	3.74	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	36.07	42.77	25.25	14.43	5.67	5.15	4.12	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	34.49	39.25	19.03	7.14	8.33	9.52	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	37.32	42.30	20.81	19.68	7.24	2.94	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	35.77	41.59	21.52	18.03	8.43	5.82	1.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	34.66	45.92	18.91	22.96	7.65	6.30	3.15	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	53.92	48.64	27.91	23.98	10.16	7.32	0.68	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	50.84	39.03	32.87	20.03	7.70	7.70	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	44.46	51.52	20.47	18.00	9.88	6.35	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	31.32	43.98	17.99	20.66	9.33	4.66	2.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	62.15	49.41	32.60	28.02	6.62	7.64	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	42.16	49.89	29.08	16.54	12.81	5.07	0.80	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	44.78	54.04	24.37	20.41	7.56	5.67	1.70	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	51.54	47.24	30.06	22.09	11.66	5.52	2.45	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	53.82	51.37	25.28	21.20	10.60	4.08	1.63	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	42.27	51.85	22.49	23.32	10.83	4.79	1.87	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	47.36	45.96	27.75	26.06	14.29	6.73	3.08	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	42.24	44.30	25.76	24.73	9.27	5.15	6.18	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	45.29	49.93	22.06	26.13	11.32	6.10	5.23	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	50.52	49.02	28.70	18.23	12.85	5.38	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	47.03	47.03	22.68	18.81	6.64	7.19	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	54.44	47.01	28.28	25.45	11.31	6.36	3.18	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	42.78	45.36	29.87	15.86	10.33	5.53	1.48	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	40.29	36.84	19.57	14.97	5.76	1.15	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	45.28	48.35	29.55	18.04	12.66	7.29	2.69	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	45.86	41.33	26.04	23.78	7.36	3.96	4.53	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	37.74	49.23	29.54	17.23	8.20	7.38	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	53.77	56.03	25.31	18.53	8.13	7.23	1.81	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	45.96	41.65	35.91	20.83	8.62	7.18	3.59	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	44.07	46.31	26.14	21.66	8.96	4.48	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	46.82	50.17	25.27	20.07	9.29	8.18	2.97	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	51.69	45.66	26.28	24.55	7.75	8.18	2.15	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	48.81	38.53	28.26	19.69	5.14	4.28	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	45.98	43.65	26.32	21.99	10.99	5.00	1.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	49.47	44.64	33.18	22.93	6.03	7.24	1.81	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	49.06	44.79	24.88	12.80	1.42	6.40	1.42	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	51.90	47.78	29.56	14.78	9.62	6.53	1.72	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	54.75	45.09	29.52	23.08	10.73	6.98	3.22	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	41.08	43.77	26.93	23.57	6.73	4.04	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	50.75	47.04	22.97	24.08	9.26	5.93	3.70	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	55.82	51.17	36.05	27.91	15.12	6.98	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	43.37	39.14	22.21	5.29	6.35	6.35	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	54.42	37.61	28.01	22.41	8.00	4.00	2.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	62.51	51.61	24.71	13.81	8.72	5.81	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	49.06	48.29	26.06	18.40	6.90	6.90	1.53	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	50.81	50.31	20.22	18.25	7.89	7.40	3.95	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	45.16	46.11	19.76	20.70	6.59	2.82	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	48.77	48.77	20.62	24.14	6.54	5.53	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	46.86	47.32	31.54	22.53	6.76	7.66	1.80	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	53.35	30.98	34.42	25.82	6.88	3.44	3.44	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	40.53	50.32	24.94	14.70	7.13	6.68	0.89	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	56.70	57.09	32.85	24.63	13.29	7.43	2.35	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	50.14	48.82	30.35	12.53	9.24	3.30	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	36.32	64.87	33.73	21.79	10.38	5.19	1.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	53.82	66.51	37.63	33.26	12.25	6.13	2.19	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	55.35	49.76	35.22	23.48	10.62	6.71	1.68	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	50.79	48.14	27.38	22.52	7.95	8.39	0.88	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	45.90	55.16	28.16	22.37	5.40	6.56	1.54	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	55.19	50.13	34.94	26.33	10.13	10.13	2.03	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	39.41	61.04	27.40	19.71	11.05	10.09	1.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	44.13	43.73	29.42	25.44	7.95	7.95	3.18	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	52.86	58.94	34.03	20.05	12.76	3.65	2.43	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	33.89	31.13	26.28	17.98	7.61	9.68	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	46.36	45.60	30.40	23.56	8.36	4.56	1.14	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	59.39	56.81	29.44	27.89	10.33	9.30	2.58	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	41.72	36.28	24.19	30.84	7.86	4.23	1.81	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	47.85	47.85	27.89	31.69	9.51	6.34	1.27	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	54.38	42.65	27.72	22.92	11.73	7.46	1.60	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	51.15	36.78	22.99	32.76	7.47	2.87	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	45.77	53.48	37.54	23.14	9.26	6.17	2.57	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	56.59	52.34	31.12	34.66	11.32	9.90	4.24	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	48.24	44.26	27.81	24.97	4.54	6.81	1.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	52.00	46.18	25.79	21.22	9.15	4.58	2.50	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	52.46	56.38	43.07	32.10	8.61	10.96	3.92	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	35.91	35.07	30.06	23.38	7.10	7.93	1.25	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	43.21	51.11	26.02	24.63	12.55	7.90	1.86	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	40.14	36.80	35.46	27.43	8.70	6.69	3.35	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	39.56	41.70	36.89	43.31	8.02	8.55	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	45.66	47.28	33.94	29.50	7.27	8.08	2.83	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	63.33	37.63	31.20	22.03	6.42	4.59	2.75	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	53.35	37.34	36.45	40.01	5.33	8.00	3.56	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	49.58	43.31	37.04	25.07	6.84	6.84	1.14	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	46.78	39.11	36.04	26.84	4.60	5.37	1.53	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	41.59	33.92	31.19	40.49	6.57	5.47	4.38	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	47.22	44.10	32.52	26.73	6.24	8.02	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	52.51	38.47	40.81	33.01	9.36	7.28	1.04	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	59.02	35.81	39.79	37.13	7.29	12.60	3.98	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	62.36	49.89	45.73	14.55	18.71	10.39	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	67.46	39.66	15.95	8.66	5.70	7.52	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	49.18	38.72	17.80	17.80	10.28	10.83	0.37	0.00
Macrophage - monocyte derived, donor3	11389-118C3	72.36	45.75	19.27	16.39	13.63	11.01	0.13	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	33.99	22.83	24.96	13.81	5.84	6.37	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	59.74	61.00	24.08	14.10	11.57	5.23	0.63	0.00
Mallassez-derived cells, donor3	11930-125I4	58.51	54.48	41.56	25.30	19.04	7.64	0.69	0.00
Mammary Epithelial Cell, donor1	11273-116H4	63.47	48.33	29.49	27.20	26.90	10.96	1.40	0.00
Mammary Epithelial Cell, donor2	11350-117G9	46.62	49.51	24.03	26.06	30.11	13.32	1.45	0.00
Mammary Epithelial Cell, donor3	11422-118F9	44.65	28.43	22.95	16.96	6.49	6.73	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	66.44	42.03	91.52	98.30	46.78	44.07	1.36	0.00
Mast cell, donor1	11563-120D6	67.26	32.23	29.09	16.65	25.95	10.92	0.65	0.00
Mast cell, donor2	11565-120D8	69.54	34.18	27.64	14.56	23.77	12.78	0.59	0.00
Mast cell, donor3	11566-120D9	85.55	46.38	40.75	27.47	30.39	13.51	0.45	0.00
Mast cell, donor4	11567-120E1	75.53	37.05	31.03	16.13	33.51	12.23	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	74.52	33.16	45.24	25.84	20.18	17.08	0.55	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	54.28	25.10	44.36	43.19	16.34	16.93	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	74.23	36.60	40.50	22.37	20.08	14.34	0.80	0.00
Mast cell, expanded, donor8	11941-126A6	81.34	29.79	30.46	15.06	29.46	13.56	1.00	0.00
Melanocyte - dark, donor1	11502-119F8	45.47	39.80	25.67	20.60	10.15	8.16	0.20	0.00
Melanocyte - dark, donor2	11582-120F7	46.38	34.95	28.38	13.84	16.96	6.58	1.04	0.00
Melanocyte - dark, donor3	11663-122F7	59.76	57.01	19.34	19.34	29.27	11.30	0.36	0.00
Melanocyte - light, donor1	11274-116H5	38.32	35.03	10.11	8.46	8.93	4.47	0.47	0.00
Melanocyte - light, donor2	11351-117H1	43.00	48.46	8.19	7.51	15.01	5.46	0.00	0.00
Melanocyte - light, donor3	11423-118G1	36.42	25.15	9.54	9.54	9.54	4.34	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	39.78	43.42	21.97	26.55	19.05	9.37	0.94	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	42.49	39.80	16.94	27.70	16.41	9.14	1.88	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	49.02	54.11	19.02	18.75	18.75	9.91	1.07	0.00
Meningeal Cells, donor1	11493-119E8	63.27	42.30	26.67	21.21	16.38	9.92	0.25	0.00
Meningeal Cells, donor2	11573-120E7	65.14	46.22	30.37	29.49	12.76	7.48	0.44	0.00
Meningeal Cells, donor3	11654-122E7	81.75	52.00	41.81	47.19	29.67	16.87	1.55	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	64.73	46.20	33.36	21.96	20.53	11.12	0.86	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	56.56	56.15	29.59	17.11	5.84	5.33	0.81	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	17.08	14.46	2.63	2.63	2.63	2.63	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	17.01	11.77	5.23	1.31	9.16	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	53.82	30.14	26.55	20.81	19.38	11.48	1.44	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	47.44	53.58	18.42	11.65	6.56	5.29	0.42	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	55.29	63.33	21.11	17.59	7.04	5.03	4.02	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	32.30	23.29	12.31	6.15	6.15	4.18	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	39.45	25.57	16.80	10.23	9.50	4.38	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	34.58	23.73	14.32	9.62	4.50	3.48	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	44.74	66.34	32.27	17.87	12.33	7.62	0.55	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	14.13	10.04	5.58	2.23	2.60	1.49	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	56.84	42.89	25.66	18.16	15.79	7.11	0.13	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	15.43	8.61	8.61	5.64	1.78	2.08	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	14.01	4.67	4.67	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	30.10	15.37	12.81	5.76	6.40	3.20	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	51.75	45.37	33.32	28.36	18.43	10.99	0.71	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	43.16	32.21	21.27	10.95	14.07	9.07	0.94	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	57.33	31.93	28.30	15.97	18.87	7.98	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	55.69	51.71	23.87	10.61	3.71	3.98	1.86	0.00
Mesothelial Cells, donor2	12156-128G5	39.54	49.05	32.53	15.51	5.51	4.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	46.90	41.26	22.40	11.56	4.12	3.83	0.22	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	64.82	89.12	39.16	14.85	27.01	10.80	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	64.03	51.72	22.16	21.92	10.10	11.82	0.49	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	58.89	52.41	23.85	28.86	15.02	15.61	1.18	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	44.94	44.94	13.83	6.91	17.29	6.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	54.55	41.53	21.08	12.09	6.51	9.61	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	42.11	31.53	15.76	20.54	11.82	11.62	0.83	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	53.27	48.64	9.26	20.84	11.58	11.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	58.81	42.79	17.77	14.52	10.01	9.01	1.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	58.65	54.00	21.88	24.20	17.69	12.57	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	38.93	0.00	0.00	38.93	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	49.58	34.95	15.65	14.63	7.93	8.94	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	46.33	42.37	26.93	29.70	10.30	10.69	1.19	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	94.07	17.10	8.55	25.65	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	40.71	30.97	15.04	10.62	13.27	9.73	1.77	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	45.21	39.13	20.14	19.00	7.98	11.78	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	52.64	32.90	9.21	22.37	10.53	3.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	40.75	30.14	13.58	8.91	6.58	6.79	0.64	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	32.23	44.20	10.13	21.18	15.65	13.81	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	44.71	32.79	8.64	9.24	6.26	7.45	0.89	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	36.89	26.83	1.68	15.09	15.09	6.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	33.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	35.38	26.60	12.55	10.04	6.52	4.01	1.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	37.08	34.70	16.87	19.25	9.74	7.13	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	40.91	33.73	7.74	12.72	7.74	6.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	31.31	26.94	11.97	9.90	5.99	4.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	43.12	35.76	19.98	23.98	8.20	8.41	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	32.61	25.07	13.45	9.58	6.32	6.11	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	39.69	30.25	12.87	10.94	6.87	4.08	0.43	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	30.45	37.57	15.56	18.45	13.56	10.89	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	20.64	0.00	10.32	0.00	20.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	21.46	26.06	13.58	9.86	6.13	6.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	32.95	23.83	12.17	17.74	11.15	10.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	21.54	23.20	9.94	14.91	14.91	9.94	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	29.35	32.34	14.68	14.13	7.07	5.44	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	40.88	31.47	20.59	20.00	12.06	8.53	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	21.81	13.08	15.26	13.08	18.54	8.72	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	18.26	22.59	19.22	9.13	5.29	5.77	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	34.82	25.21	24.41	23.61	8.40	8.81	2.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	20.57	24.68	17.83	12.34	12.34	5.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	19.02	20.52	19.52	15.02	5.51	8.51	1.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	26.95	80.84	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	16.31	18.35	6.12	8.15	8.15	4.08	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	22.77	20.58	29.78	20.58	6.13	6.57	0.88	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	25.38	27.59	14.35	9.93	20.97	16.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	28.18	19.85	14.09	10.89	14.09	7.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	21.82	23.80	29.75	21.07	6.69	9.17	0.50	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	25.75	23.66	18.79	18.09	13.22	7.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	26.52	22.10	2.21	11.05	19.89	6.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	26.67	20.85	21.88	12.65	7.86	8.55	1.03	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	34.13	22.76	17.07	21.01	14.00	6.56	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	30.89	24.15	11.36	13.85	11.36	4.97	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	27.21	29.18	27.49	16.27	10.38	10.38	1.12	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	40.73	31.59	28.68	29.09	19.53	15.79	0.83	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	36.71	25.06	8.16	11.65	11.07	6.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	38.91	25.64	29.56	14.48	12.97	8.75	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	41.32	37.57	32.14	29.22	15.86	17.11	1.67	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	43.31	28.88	0.00	0.00	21.66	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	34.17	24.01	18.47	14.78	13.85	6.46	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	47.81	36.42	34.72	26.18	18.21	11.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	37.59	22.94	18.52	16.86	7.05	6.91	0.28	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	31.88	17.10	22.29	14.51	10.11	5.44	0.52	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	44.18	34.32	25.74	24.02	16.30	15.87	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	48.27	22.23	17.79	10.16	7.62	6.99	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	37.10	28.82	22.95	12.81	12.54	7.47	0.53	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	60.46	35.02	32.03	24.55	10.78	12.57	0.60	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	34.89	20.34	18.50	12.85	6.64	5.65	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	34.40	21.34	21.66	13.06	7.64	6.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	51.52	34.05	29.19	23.00	14.37	11.50	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	47.78	30.72	11.76	12.13	10.24	5.69	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	39.21	25.57	22.44	11.08	8.81	7.95	0.85	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	50.88	29.74	27.04	18.68	9.83	7.37	0.49	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	58.00	19.55	8.47	5.87	10.43	4.56	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	51.75	29.99	20.29	13.82	8.23	7.06	0.59	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	57.09	35.75	27.68	18.74	8.94	10.67	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	68.42	31.74	16.07	14.01	14.84	10.72	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	50.33	29.78	16.38	13.10	8.64	11.02	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	18.83	7.53	0.00	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	44.56	19.60	14.26	12.48	5.35	5.35	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	54.21	39.43	13.47	8.54	6.57	6.57	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	52.60	23.14	8.42	2.10	9.47	4.21	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	50.21	29.26	13.24	8.70	7.12	6.13	0.79	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	61.47	40.98	33.53	15.83	12.11	14.90	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	58.21	43.19	11.27	7.89	7.51	7.14	1.88	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	44.21	29.83	10.92	7.72	4.79	4.26	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	44.90	31.44	16.85	5.77	5.88	5.77	0.23	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	43.47	24.31	10.31	9.58	6.63	5.89	2.95	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	50.57	43.24	14.29	4.76	3.30	6.23	1.83	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	51.33	38.89	7.78	9.33	3.11	7.78	7.78	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	44.36	30.46	13.90	8.55	7.48	3.21	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	34.78	23.18	7.73	3.86	0.00	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	47.47	22.22	8.08	5.05	7.07	1.01	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	36.26	34.57	8.85	7.59	6.32	6.32	1.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	10.90	19.07	8.17	5.45	9.53	8.17	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	11.44	9.54	2.54	3.81	2.54	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	20.25	12.96	1.62	2.43	1.62	3.24	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	27.19	13.59	4.53	10.57	9.06	4.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	39.97	57.10	34.26	17.13	62.81	28.55	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	22.84	39.15	19.57	39.15	29.36	9.79	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	33.27	23.76	47.52	28.51	33.27	9.50	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	62.75	75.29	25.10	62.75	87.84	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	53.43	76.26	20.90	9.26	3.88	5.39	0.86	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	91.46	72.64	21.95	8.88	3.66	6.27	1.05	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	96.12	56.74	32.04	15.35	6.67	4.00	1.33	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	60.52	36.73	19.20	10.43	7.51	3.76	1.25	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	56.47	64.27	33.46	14.26	9.32	3.80	1.52	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	94.16	108.52	43.09	17.55	49.47	19.15	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	70.71	51.68	23.12	9.52	2.04	1.36	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	170.90	271.97	88.21	42.27	29.40	14.70	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	89.98	45.20	22.18	8.79	1.67	2.51	1.26	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	71.36	63.22	23.01	14.41	6.74	4.88	1.63	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	98.63	56.21	32.97	11.08	4.86	6.22	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	99.65	81.15	32.38	14.30	7.99	6.73	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	389.72	623.54	178.16	55.67	66.81	55.67	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	96.79	58.07	22.83	10.92	3.47	1.49	2.98	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	44.66	38.16	15.70	3.79	1.62	3.25	1.35	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	64.15	46.92	21.76	7.25	2.95	2.49	2.04	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	85.24	51.11	23.84	6.70	3.10	2.78	1.14	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	71.81	51.03	30.62	11.48	6.20	3.65	0.36	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	76.38	55.70	16.44	7.96	4.77	1.06	1.06	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	97.25	52.83	23.41	10.21	3.00	4.20	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	41.35	55.13	27.57	8.86	5.91	2.95	2.63	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	69.28	42.28	18.54	6.83	2.28	2.93	1.14	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	67.91	58.74	31.22	14.99	8.64	3.00	0.71	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	77.36	56.26	27.43	6.33	4.22	2.81	2.11	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	86.89	54.71	25.28	7.82	4.14	3.22	1.84	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	84.19	56.56	26.67	10.28	4.50	2.57	1.29	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	25.87	55.87	26.56	7.59	5.86	1.03	2.76	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	134.01	275.60	101.14	45.51	25.28	7.59	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	59.48	71.07	27.18	13.37	8.02	6.02	0.67	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	67.74	33.02	21.59	9.74	5.93	0.42	1.27	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	51.98	46.05	23.50	4.75	3.56	1.42	1.42	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	97.87	69.97	28.76	17.17	2.15	4.72	0.86	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	279.86	622.92	189.58	117.36	90.28	63.19	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	76.31	54.98	28.32	5.66	4.00	4.33	0.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	51.85	68.98	22.99	13.53	11.27	4.96	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	67.06	45.63	28.57	11.90	2.38	2.38	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	79.86	65.93	29.72	7.43	3.71	1.86	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	48.43	51.46	24.22	5.68	3.78	0.76	0.76	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	73.00	52.79	26.72	12.06	4.89	1.96	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	69.29	56.65	21.79	9.15	3.92	3.05	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	48.39	72.37	34.83	15.38	10.40	5.88	1.36	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	61.73	50.27	25.58	11.46	5.29	0.88	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	86.43	67.15	25.93	13.96	7.31	3.32	3.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	92.26	83.34	38.69	11.41	3.47	5.46	1.49	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	68.53	47.85	22.59	15.31	3.83	1.91	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	73.80	73.19	30.24	8.47	7.26	2.72	1.51	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	61.00	81.12	37.13	13.48	5.53	4.20	1.33	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	73.86	60.99	17.62	10.84	6.10	2.71	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	143.07	306.57	112.41	30.66	25.55	25.55	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	86.57	76.21	38.41	12.19	4.88	4.27	1.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	52.25	42.17	23.29	11.33	3.78	1.89	0.63	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	81.41	56.29	31.17	7.87	3.63	3.03	0.91	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	68.83	47.47	37.18	11.08	3.96	2.37	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	40.81	71.42	29.47	11.34	6.80	3.40	4.53	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	116.33	343.94	126.45	25.29	15.17	10.12	0.00	0.00
Myoblast, donor1	11241-116D8	62.24	52.55	30.44	21.62	9.07	5.34	0.75	0.00
Myoblast, donor2	11322-117D8	82.28	75.37	41.23	23.21	9.97	6.71	2.11	0.00
Myoblast, donor3	11398-118D3	91.82	74.50	32.62	16.82	5.04	3.70	1.35	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	72.09	46.70	48.45	21.60	16.05	8.76	0.88	0.00
Natural Killer Cells, donor1	11230-116C6	35.67	47.05	36.29	19.37	11.69	7.07	0.92	0.00
Natural Killer Cells, donor2	11311-117C6	31.36	51.26	34.68	13.57	11.16	3.62	0.90	0.00
Natural Killer Cells, donor3	11387-118C1	36.07	56.69	28.34	16.01	10.86	6.99	0.00	0.00
Neural stem cells, donor1	11275-116H6	209.42	161.51	113.96	96.90	72.23	26.86	1.81	0.00
Neural stem cells, donor2	11352-117H2	171.38	161.75	125.17	77.03	69.32	34.66	0.00	0.00
Neurons, donor1	11494-119E9	86.48	77.38	68.27	46.65	35.27	11.38	3.41	0.00
Neurons, donor2	11574-120E8	130.12	69.13	76.84	44.25	26.86	18.49	1.32	0.00
Neurons, donor3	11655-122E8	80.57	55.09	56.73	43.57	23.02	9.87	5.76	0.00
Neutrophils, donor1	11233-116C9	33.41	36.19	11.14	12.06	15.78	2.78	4.64	0.00
Neutrophils, donor2	11314-117C9	43.48	17.39	14.49	11.60	5.80	2.90	2.90	0.00
Neutrophils, donor3	11390-118C4	45.20	48.87	25.04	11.61	20.77	6.11	1.22	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	69.94	43.34	34.08	18.05	18.40	11.40	1.07	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	49.49	25.07	14.65	12.05	13.35	6.84	2.28	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	41.31	35.90	23.06	14.84	5.21	6.02	0.40	0.00
Olfactory epithelial cells, donor1	11933-125I7	48.45	41.85	17.07	8.12	6.06	4.40	0.96	0.00
Olfactory epithelial cells, donor2	11934-125I8	54.42	48.49	19.25	11.15	5.93	3.33	4.49	0.00
Olfactory epithelial cells, donor3	11935-125I9	58.23	45.63	19.07	9.19	5.56	3.86	0.34	0.00
Olfactory epithelial cells, donor4	11936-126A1	73.53	56.49	25.23	11.88	6.92	4.48	0.68	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	45.14	63.19	30.69	24.67	22.87	9.63	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	54.66	71.04	29.35	11.91	7.23	4.89	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	35.44	33.15	9.14	9.14	1.14	1.14	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	33.52	21.72	8.69	3.10	5.59	1.86	1.24	0.00
Osteoblast, donor1	11277-116H8	46.51	53.35	25.80	13.29	8.79	3.32	0.20	0.00
Osteoblast, donor2	11354-117H4	80.06	97.62	58.99	26.69	14.75	9.13	0.70	0.00
Osteoblast, donor3	11426-118G4	80.51	90.64	35.01	22.93	11.20	6.22	0.53	0.00
Pancreatic stromal cells, donor1	11249-116E7	63.85	59.64	34.20	19.54	11.37	7.41	0.84	0.00
Pericytes, donor1	11491-119E6	12.91	9.12	5.12	2.00	1.34	1.11	0.00	0.00
Pericytes, donor2	11571-120E5	15.85	12.22	3.17	1.81	1.13	3.17	0.45	0.00
Pericytes, donor3	11652-122E5	24.41	17.70	9.16	6.71	2.24	2.24	0.00	0.00
Perineurial Cells, donor1	11499-119F5	51.20	44.76	30.97	21.02	15.60	10.85	0.45	0.00
Perineurial Cells, donor2	11579-120F4	61.19	45.55	32.66	20.06	18.77	11.78	0.00	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	79.37	44.94	49.40	21.99	27.09	8.61	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	51.91	35.02	23.51	10.77	14.69	8.08	0.24	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	46.20	35.33	31.58	15.14	12.55	6.99	0.39	0.00
Placental Epithelial Cells, donor1	11278-116H9	23.20	17.70	12.44	8.61	4.78	1.20	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	41.03	23.29	16.63	4.44	5.54	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	31.81	25.72	8.05	3.93	5.69	1.96	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	23.73	22.15	7.91	5.70	1.90	0.95	1.90	0.00
Preadipocyte - breast, donor1	11467-119B9	55.34	51.21	25.89	5.63	4.13	2.44	0.75	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	86.93	80.67	42.16	15.27	8.61	5.87	0.91	0.00
Preadipocyte - breast, donor2	11328-117E5	51.56	49.76	18.24	7.88	4.28	2.25	1.13	0.00
Preadipocyte - omental, donor1	11468-119C1	63.08	53.49	19.93	9.59	4.48	4.26	0.85	0.00
Preadipocyte - omental, donor2	11329-117E6	69.40	78.13	24.01	10.91	4.80	5.24	2.18	0.00
Preadipocyte - omental, donor3	11403-118D8	58.88	56.15	21.77	10.74	4.58	2.01	1.15	0.00
Preadipocyte - perirenal, donor1	11469-119C2	26.58	34.45	12.80	3.94	1.97	0.98	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	39.93	40.23	32.25	11.67	5.22	3.99	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	84.47	69.24	44.62	35.06	23.91	16.65	4.25	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	52.45	52.45	26.90	16.69	5.62	5.79	0.34	0.00
Preadipocyte - visceral, donor1	11280-116I2	95.57	90.63	59.80	34.93	18.44	12.02	0.56	0.00
Preadipocyte - visceral, donor2	11357-117H7	79.15	57.52	42.80	25.77	10.12	11.04	4.60	0.00
Preadipocyte - visceral, donor3	11429-118G7	61.13	56.53	35.00	22.57	12.75	8.99	1.04	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	55.36	68.94	66.38	58.53	13.28	7.84	1.66	0.00
Prostate Epithelial Cells, donor2	11331-117E8	44.01	41.71	25.19	21.80	7.58	4.47	2.03	0.00
Prostate Epithelial Cells, donor3	11404-118D9	36.99	24.56	15.68	13.29	7.35	3.25	1.35	0.00
Prostate Stromal Cells, donor1	11254-116F3	56.49	45.79	39.87	29.73	16.06	7.86	0.91	0.00
Prostate Stromal Cells, donor2	11332-117E9	33.35	32.09	19.36	14.34	6.81	6.28	1.79	0.00
Prostate Stromal Cells, donor3	11405-118E1	51.72	46.92	19.81	10.95	4.80	4.48	1.04	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	17.52	13.50	10.58	5.11	5.47	2.92	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	56.56	37.77	24.95	20.10	16.70	8.73	1.18	0.00
Renal Epithelial Cells, donor1	11517-119H5	18.77	12.68	9.64	5.58	4.57	2.54	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	13.52	12.80	17.07	9.96	7.11	3.56	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	66.17	45.31	37.90	23.82	18.63	9.95	0.74	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	28.60	8.17	8.85	4.77	0.68	3.40	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	39.22	19.41	18.73	16.58	7.14	4.45	0.27	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	65.94	55.28	39.30	24.20	19.09	12.43	0.67	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	17.97	11.31	7.99	2.66	2.00	1.33	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	22.89	14.31	14.75	8.36	2.64	2.86	0.66	0.00
Renal Mesangial Cells, donor2	11598-120H5	36.99	15.67	15.05	11.91	6.90	3.13	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	11.65	6.10	8.04	3.05	3.05	2.22	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	45.90	28.45	19.86	12.08	8.59	3.49	0.54	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	22.77	12.65	9.70	6.75	4.64	2.95	1.27	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	32.01	16.39	14.27	7.71	4.82	3.09	0.19	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	59.89	49.78	35.52	30.60	23.34	12.70	0.78	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	43.21	24.45	29.85	14.50	4.83	4.83	0.57	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	27.79	15.44	13.38	7.20	3.09	3.09	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	54.45	32.12	35.13	27.10	21.33	8.78	0.75	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	60.54	47.98	23.52	17.77	8.82	5.75	0.67	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	82.19	41.99	59.86	24.12	26.80	7.15	1.79	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	67.70	55.04	93.56	31.92	23.67	15.96	1.10	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	77.73	81.21	86.43	39.44	39.44	12.18	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	88.42	81.92	68.78	39.01	13.52	8.97	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	86.30	56.21	49.26	29.79	13.11	7.05	1.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	96.93	65.70	73.17	37.25	14.05	7.47	1.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	102.71	75.17	81.99	38.33	12.65	9.06	1.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	82.05	51.28	52.68	28.20	10.49	6.29	1.98	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	90.14	65.18	65.41	34.90	15.02	6.70	2.77	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	87.62	72.01	65.85	28.61	11.09	7.26	1.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	81.99	57.18	53.70	27.53	13.61	6.05	2.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	107.51	58.77	71.32	37.63	13.62	8.24	0.72	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	88.37	64.41	64.70	29.41	12.77	8.32	1.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	75.66	50.76	47.65	26.51	11.91	6.98	2.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	91.61	54.65	51.78	32.53	11.95	3.10	0.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	98.84	88.71	63.28	24.85	14.91	8.03	0.96	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	83.66	55.99	48.17	25.62	14.16	6.15	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	123.64	64.64	83.43	42.65	15.22	4.89	1.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	90.64	76.31	57.20	28.00	14.73	5.84	1.99	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	89.16	60.35	48.57	31.25	12.85	5.45	1.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	89.75	64.54	61.87	30.94	13.37	6.68	2.86	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	83.41	62.58	55.43	26.48	11.75	6.94	1.07	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	72.88	55.22	51.30	20.74	11.21	5.33	2.52	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	91.60	67.16	61.87	27.34	12.82	5.81	1.03	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	91.53	76.58	50.87	28.99	10.76	7.84	0.73	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	77.63	50.65	44.15	27.47	13.12	5.52	1.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	90.93	67.03	59.10	30.49	13.83	5.37	1.88	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	102.60	84.68	79.02	30.43	9.43	8.73	2.59	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	85.71	57.54	40.87	27.98	13.69	3.57	2.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	92.60	74.60	61.03	30.40	14.26	7.72	1.87	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	90.82	75.06	63.24	27.16	10.78	7.05	1.87	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	84.50	63.49	54.42	29.42	12.17	5.75	4.65	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	93.58	68.93	53.27	25.48	17.13	5.43	1.67	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	95.69	79.94	62.72	30.55	10.23	5.11	1.88	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	100.13	73.57	49.04	29.12	18.73	7.49	0.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	93.70	69.21	54.56	32.78	15.81	5.21	1.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	97.66	89.06	62.93	35.76	14.61	10.66	2.75	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	89.02	65.84	43.21	29.77	17.83	6.86	0.82	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	94.56	67.31	53.68	34.48	17.24	8.21	1.64	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	87.77	70.39	63.91	31.19	15.85	8.52	1.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	89.66	60.66	58.89	35.21	17.02	7.84	0.74	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	89.29	64.77	62.11	36.78	15.46	6.93	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	78.95	48.12	53.09	32.77	15.76	9.96	1.52	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	70.72	46.19	52.14	30.24	13.33	6.19	0.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	109.24	72.15	74.17	33.86	15.12	10.08	0.81	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	72.33	49.63	46.05	24.11	13.28	7.63	1.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	86.64	45.42	43.32	32.49	26.90	11.88	2.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	74.65	42.31	38.99	27.20	20.55	8.16	1.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	73.55	54.22	49.08	31.70	15.18	8.44	1.84	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	115.28	69.57	71.76	41.05	33.19	8.15	0.73	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	75.45	56.58	57.19	26.77	16.43	7.91	1.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	83.49	59.38	57.27	27.43	12.66	10.25	1.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	84.37	50.21	49.08	31.89	19.23	7.92	2.26	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	85.97	57.81	59.91	25.46	20.97	11.08	1.80	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	65.06	50.65	55.38	35.07	21.49	10.27	1.42	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	85.38	45.04	44.18	32.87	21.77	6.19	2.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	90.15	45.67	57.69	36.06	26.44	8.41	1.80	0.60
Schwann Cells, donor1	11498-119F4	22.57	12.60	6.39	7.71	5.83	2.44	0.00	0.00
Schwann Cells, donor2	11578-120F3	44.23	44.23	27.22	20.41	13.61	10.21	0.00	0.00
Schwann Cells, donor3	11659-122F3	48.20	40.97	24.54	12.93	12.93	9.20	3.29	0.00
Sebocyte, donor1	11220-116B5	75.59	54.23	44.92	35.61	11.50	7.67	0.55	0.00
Sebocyte, donor2	11301-117B5	45.04	31.25	21.60	15.17	5.06	4.14	0.46	0.00
Sebocyte, donor3	11378-118B1	38.54	37.92	16.90	10.31	7.63	1.65	1.65	0.00
Sertoli Cells, donor1	11255-116F4	53.01	48.04	19.88	18.22	14.91	6.63	0.00	0.00
Sertoli Cells, donor2	11333-117F1	73.43	48.01	36.72	8.47	16.95	8.47	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	63.34	42.41	28.24	18.92	12.32	6.51	0.79	0.00
Skeletal Muscle Cells, donor2	11358-117H8	23.13	18.07	6.51	6.51	2.17	3.61	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	72.74	55.18	37.62	30.10	20.06	13.38	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	72.58	52.78	45.56	35.19	21.99	15.24	0.94	0.00
Skeletal Muscle Cells, donor5	11455-119A6	72.24	47.57	39.09	32.40	22.74	14.86	0.59	0.00
Skeletal Muscle Cells, donor6	11459-119B1	63.25	41.86	45.71	45.40	36.01	21.85	0.31	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	86.94	54.43	31.00	23.19	35.53	16.88	1.26	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	88.04	51.65	31.39	29.39	30.96	14.70	1.57	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	86.02	48.61	56.35	48.41	32.04	15.18	1.98	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	68.24	68.33	31.09	18.96	9.60	4.63	0.51	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	53.56	31.12	19.54	16.65	13.75	8.69	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	58.48	53.94	22.02	12.66	5.37	4.54	0.14	0.00
Skin - palm, donor1	10286-104F7	94.01	37.61	10.74	10.74	24.17	24.17	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	39.64	32.00	21.62	9.66	2.31	2.74	0.86	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	138.22	112.87	76.88	22.08	5.73	4.91	2.45	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	53.62	25.45	19.86	9.09	7.14	4.28	1.56	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	43.93	33.64	15.15	15.15	14.18	6.12	1.11	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	37.41	26.30	16.74	14.35	9.14	5.06	0.28	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	101.07	78.23	52.44	27.07	20.72	9.73	0.63	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	51.04	28.33	14.39	17.46	12.59	5.25	0.67	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	41.97	45.36	19.13	10.49	5.86	2.47	1.54	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	64.03	81.15	36.02	18.68	4.67	4.45	1.33	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	65.25	55.26	22.34	7.05	6.47	2.35	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	47.07	54.36	36.02	20.33	10.83	10.61	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	51.59	43.32	35.83	17.72	5.91	3.54	0.79	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	57.94	44.81	20.09	13.91	7.73	3.86	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	62.05	28.02	16.01	15.01	23.02	3.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	58.95	49.77	29.14	16.37	3.99	3.86	0.40	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	45.22	61.40	24.16	13.30	6.21	6.43	1.11	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	93.33	90.01	41.23	39.43	13.32	9.99	0.64	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	71.96	48.84	23.44	20.19	14.98	7.81	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	67.92	67.63	32.49	18.31	8.86	9.75	0.89	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	51.96	43.42	24.91	18.36	7.55	3.13	0.57	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	12.04	11.06	8.30	2.44	1.14	1.14	0.33	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	54.49	48.10	25.27	13.70	12.48	6.70	1.52	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	68.70	82.84	26.52	12.88	6.57	3.79	0.51	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	24.48	6.12	79.57	30.60	30.60	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	37.19	21.46	21.46	15.74	4.77	2.86	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	52.65	38.93	29.79	22.56	13.27	9.14	0.74	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	57.04	47.14	29.49	18.08	13.99	10.55	1.29	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	61.72	51.53	31.28	22.25	14.27	10.18	0.63	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	51.35	60.48	40.06	21.96	6.34	3.87	0.77	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	38.80	52.82	29.10	20.48	3.23	2.16	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	57.08	41.24	29.59	21.52	8.07	5.08	0.60	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	17.07	7.17	10.58	5.46	2.39	1.02	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	66.67	39.66	24.50	17.83	17.83	10.84	0.63	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	66.83	78.90	33.31	19.22	7.95	4.03	1.61	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	49.61	50.06	33.00	25.03	7.51	7.28	1.37	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	35.62	19.93	25.36	6.64	4.83	3.62	1.81	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	84.78	66.50	74.44	56.96	32.06	22.78	1.32	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	60.05	57.26	26.76	20.51	9.99	8.39	0.67	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	64.61	45.08	28.68	16.65	7.64	3.76	2.13	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	31.20	48.20	15.22	8.62	6.34	3.04	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	70.56	60.16	39.20	17.49	8.90	4.82	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	39.01	37.51	14.25	9.75	2.25	3.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	81.41	153.77	49.10	27.14	47.81	38.77	2.58	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	61.39	58.60	36.74	16.74	6.98	8.84	1.40	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	42.91	35.34	19.69	13.13	6.56	5.05	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	49.83	42.62	26.64	25.07	6.58	7.21	1.57	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	13.27	18.58	7.37	1.77	3.54	1.47	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	103.97	88.56	58.65	39.57	31.24	16.83	0.75	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	55.12	37.84	23.83	13.08	8.41	7.01	1.40	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	47.92	52.96	28.06	18.28	6.33	3.74	0.29	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	53.29	37.99	28.56	15.55	10.96	5.35	0.51	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	49.08	32.72	23.88	16.92	6.21	5.83	0.56	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	63.16	50.59	39.83	27.81	22.92	12.44	0.56	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	44.99	39.46	24.38	12.48	9.97	4.36	0.25	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	11.90	3.81	6.19	2.86	2.86	2.86	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	42.57	49.91	23.73	14.68	5.38	4.65	0.24	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	43.31	46.40	31.82	21.43	5.74	4.64	1.33	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	39.50	26.04	17.55	12.29	13.46	8.78	0.59	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	53.06	46.06	19.24	6.41	4.08	3.89	0.58	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	46.01	55.01	14.54	6.61	5.29	2.91	2.38	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	42.03	56.16	24.18	14.88	7.44	5.58	1.86	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	41.68	73.66	24.43	11.14	8.98	2.52	1.44	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	49.97	64.16	23.56	11.07	8.23	4.26	0.85	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	52.78	54.75	35.05	17.33	14.57	6.30	1.58	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	34.79	50.03	21.84	7.87	4.83	2.54	2.29	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	37.94	38.33	13.18	7.19	3.59	2.40	1.60	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	49.74	58.52	20.48	3.76	2.09	2.09	2.51	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	49.04	48.59	17.42	6.42	6.88	1.38	0.46	0.00
Synoviocyte, donor1	11291-117A4	44.77	49.49	26.26	15.49	6.56	4.38	1.01	0.00
Synoviocyte, donor2	11368-117I9	48.95	54.81	16.76	7.71	4.36	3.02	1.68	0.00
Synoviocyte, donor3	11440-118H9	48.48	52.05	20.78	6.70	1.79	6.26	1.34	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	32.87	25.73	19.30	10.36	5.00	2.86	0.71	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	7.93	7.93	5.95	5.95	1.98	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	30.33	13.66	8.80	6.48	6.02	3.70	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	38.42	21.00	23.01	20.43	14.98	7.67	0.14	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	28.22	24.74	18.17	10.44	6.96	2.32	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	22.91	17.75	12.03	14.32	6.30	4.58	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	62.99	49.46	30.39	16.24	7.87	6.64	0.86	0.00
Urethra, donor2	10319-105A4	102.51	71.94	19.78	10.79	34.17	17.98	1.80	0.00
Urothelial Cells, donor1	11520-119H8	11.42	13.81	9.30	4.25	0.80	2.13	0.00	0.00
Urothelial Cells, donor2	11600-120H7	13.22	10.82	6.01	4.81	3.20	3.61	0.80	0.00
Urothelial Cells, donor3	11681-122H7	13.06	9.40	6.88	2.98	1.60	0.92	0.23	0.00
Urothelial cells, donor0	11216-116B1	45.47	38.12	25.86	20.95	16.27	7.80	0.67	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	71.18	39.15	39.15	19.58	5.34	7.12	1.78	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	61.47	32.88	34.31	12.87	5.72	7.15	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	51.34	23.27	24.64	10.27	6.16	4.79	4.79	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	60.60	30.99	29.96	8.95	12.05	5.17	1.03	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	61.01	31.38	36.02	16.27	12.78	9.30	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	62.47	34.36	35.40	11.45	4.16	8.33	3.12	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	50.48	32.12	38.55	10.10	12.85	8.26	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	49.30	21.91	31.04	9.13	7.30	4.56	1.83	0.00
Wilms' tumor cell line:G-401	10809-111A8	83.15	59.58	48.73	38.86	15.42	10.12	1.85	0.00
Wilms' tumor cell line:HFWT	10597-108E3	82.72	37.84	27.28	19.36	5.28	3.52	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	186.03	119.55	92.73	71.78	41.62	22.35	1.68	0.00
achilles tendon, donor2	10292-104G4	33.06	33.06	16.53	26.86	10.33	6.20	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	83.12	31.87	69.35	31.36	44.11	11.47	3.31	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	90.55	52.24	82.65	51.31	32.27	22.06	0.46	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	114.67	59.59	136.28	54.25	33.71	19.35	0.95	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	89.25	67.48	156.74	56.87	17.14	18.23	2.72	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	83.48	62.12	75.89	65.49	58.18	19.96	2.53	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	63.87	51.18	64.50	33.84	27.70	13.75	0.21	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	94.73	52.54	77.31	55.53	71.59	20.96	2.18	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	109.28	108.84	82.40	41.42	27.76	12.78	1.32	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	97.19	67.38	85.76	38.39	27.36	18.38	1.63	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	114.16	92.80	76.11	53.20	58.63	23.30	3.11	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	98.26	41.40	79.67	62.19	64.95	28.89	3.31	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	144.32	50.71	105.31	31.20	62.41	7.80	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	71.34	50.89	87.84	38.11	20.91	10.92	2.32	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	117.54	111.85	101.49	49.97	51.00	16.31	3.62	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	142.32	90.89	104.33	48.80	30.98	20.46	2.34	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	79.94	71.11	52.98	29.74	39.97	16.73	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	113.09	64.98	35.37	11.10	14.81	9.87	0.82	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	79.81	52.49	60.78	55.86	34.07	23.02	1.23	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	114.78	99.85	74.67	78.51	47.36	22.19	2.13	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	139.21	101.60	64.60	76.13	41.25	20.32	1.21	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	143.46	94.60	72.93	76.79	49.59	27.68	0.72	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	86.20	67.94	57.69	35.19	33.41	17.60	1.11	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	128.08	116.07	46.03	38.02	43.69	14.34	1.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	102.20	72.47	42.74	35.31	53.89	35.31	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	50.10	44.07	48.97	26.74	16.20	5.27	0.75	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	111.65	62.80	70.22	48.41	144.80	30.97	1.74	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	52.48	46.86	44.99	22.49	39.36	11.25	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	70.89	54.40	23.79	12.95	8.01	8.71	0.94	0.00
adipose tissue, adult, pool1	10010-101C1	65.77	44.52	21.72	17.84	11.94	10.86	0.00	0.00
adipose, donor1	10184-103D4	82.68	59.81	99.69	81.51	58.64	22.28	3.52	0.00
adipose, donor2	10185-103D5	90.43	28.79	33.25	35.69	33.25	10.54	0.41	0.00
adipose, donor3	10186-103D6	83.32	39.48	38.66	49.28	31.86	13.34	2.18	0.00
adipose, donor4	10187-103D7	69.34	32.07	45.07	96.21	41.60	17.34	2.60	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	139.04	67.07	54.76	28.57	9.63	7.26	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	80.03	25.46	18.19	7.28	10.91	7.28	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	58.30	37.49	26.55	19.08	29.35	10.27	0.27	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	103.26	86.82	55.74	30.01	19.29	10.72	1.43	0.00
amniotic membrane cells, donor1	12235-129G3	40.57	34.78	8.81	8.11	9.27	4.87	0.46	0.00
amniotic membrane cells, donor2	12236-129G4	63.56	59.51	16.57	18.26	9.13	9.80	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	35.06	37.71	5.89	7.07	7.37	3.24	0.00	0.00
amygdala - adult, donor10196	10167-103B5	110.28	71.15	16.60	11.86	11.86	13.04	1.19	0.00
amygdala, adult, donor10252	10151-102I7	122.47	64.07	17.44	10.34	9.12	8.72	1.62	0.00
amygdala, newborn, donor10223	10360-105E9	91.99	41.31	30.99	23.56	16.46	9.68	0.65	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	73.98	44.31	27.25	21.90	19.10	5.73	0.38	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	59.13	36.84	51.63	37.06	27.36	13.68	1.54	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	116.91	101.55	55.45	52.11	43.76	27.39	1.34	0.33
aorta, adult, pool1	10052-101G7	49.82	31.77	18.63	9.22	9.41	5.69	0.78	0.00
appendix, adult	10189-103D9	73.74	53.17	51.62	21.73	14.75	14.36	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	94.93	42.65	77.04	45.74	28.55	16.16	2.75	0.00
artery, adult	10190-103E1	48.91	36.68	10.87	5.43	6.79	4.08	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	179.06	95.47	60.55	42.74	45.49	28.83	0.58	0.00
b cell line:RPMI1788	10427-106D4	76.43	25.73	48.77	40.15	45.06	24.98	0.59	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	46.61	58.54	20.25	13.32	5.55	3.88	1.94	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	107.27	83.16	75.02	47.23	18.75	9.43	0.50	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	33.98	26.11	22.09	20.09	6.36	7.03	0.33	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	104.02	73.82	40.82	36.35	99.54	10.07	1.68	0.00
bladder, adult, pool1	10011-101C2	51.71	36.83	23.79	20.42	17.38	11.73	0.33	0.00
blood, adult, pool1	10053-101G8	37.65	13.29	17.72	8.86	8.86	4.43	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	70.22	107.04	22.27	10.28	7.71	8.56	0.00	0.00
bone marrow, adult	10192-103E3	90.43	66.81	41.16	20.92	16.20	11.47	6.07	0.00
brain, adult, donor1	10084-102B3	103.53	32.80	13.33	12.30	6.15	9.23	1.03	0.00
brain, adult, pool1	10012-101C3	110.02	52.00	5.79	11.36	9.80	8.35	0.67	0.00
brain, fetal, pool1	10085-102B4	181.66	53.43	48.09	45.41	24.04	18.70	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	82.59	61.78	27.09	32.71	37.66	13.54	1.32	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	98.36	89.37	33.45	29.21	9.86	9.36	0.25	0.00
breast, adult, donor1	10080-102A8	75.13	35.36	33.46	12.00	6.31	9.47	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	74.70	18.29	80.80	48.91	9.65	11.81	1.52	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	39.27	19.48	48.86	28.45	10.82	10.82	0.62	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	58.25	26.71	51.11	25.32	6.22	7.60	2.99	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	31.47	22.51	17.67	23.97	15.01	9.93	0.48	0.00
carcinoid cell line:NCI-H1770	10703-109H1	112.84	42.32	37.61	32.44	25.86	11.28	0.94	0.00
carcinoid cell line:NCI-H727	10735-110B6	91.00	70.55	60.38	44.52	34.35	13.45	0.98	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	56.09	74.15	62.75	33.91	16.16	6.02	2.54	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	126.17	72.67	83.31	58.83	59.36	21.29	3.19	0.00
caudate nucleus - adult, donor10196	10177-103C6	126.65	80.59	19.57	11.51	18.42	8.06	3.45	0.00
caudate nucleus, adult, donor10252	10164-103B2	117.30	56.05	18.74	14.72	8.70	9.70	1.34	0.00
caudate nucleus, adult, donor10258	10379-105H1	162.00	57.31	14.52	12.99	6.11	9.17	2.29	0.00
caudate nucleus, newborn, donor10223	10354-105E3	108.41	55.30	47.24	27.47	17.21	13.55	1.83	0.00
cerebellum - adult, donor10196	10173-103C2	177.71	72.83	11.65	8.74	8.74	20.39	5.83	0.00
cerebellum, adult, donor10252	10166-103B4	170.59	70.03	28.82	17.93	9.39	7.69	1.71	0.00
cerebellum, adult, pool1	10083-102B2	112.45	30.70	10.35	7.93	8.28	7.24	1.72	0.00
cerebellum, newborn, donor10223	10357-105E6	120.39	73.07	72.23	24.08	14.11	8.30	1.66	0.00
cerebral meninges, adult	10188-103D8	106.65	52.19	7.06	12.61	11.85	8.82	0.25	0.25
cerebrospinal fluid, donor2	10294-104G6	69.43	29.24	8.04	10.23	11.69	2.19	1.46	0.00
cervical cancer cell line:D98-AH2	10552-107I3	48.31	39.40	30.19	18.55	10.93	5.18	0.58	0.00
cervical cancer cell line:ME-180	10553-107I4	45.74	61.65	45.74	28.83	12.10	7.62	0.50	0.00
cervix, adult, pool1	10013-101C4	72.23	49.03	23.83	19.42	19.53	14.49	0.84	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	74.41	52.81	26.75	20.62	10.59	5.57	0.70	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	36.58	33.96	13.06	5.23	7.84	5.23	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	60.03	34.92	40.39	45.61	32.19	12.05	1.49	0.00
choriocarcinoma cell line:SCH	10785-110H2	48.30	18.24	21.07	24.64	11.95	8.13	1.23	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	30.12	13.76	10.67	14.23	16.37	7.35	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	29.92	27.92	11.11	8.83	7.41	4.84	0.57	0.00
chorionic membrane cells, donor2	12239-129G7	67.61	68.31	33.11	20.28	11.43	7.06	0.99	0.00
chorionic membrane cells, donor3	12240-129G8	42.86	39.56	19.23	12.64	9.34	7.69	1.65	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	49.48	75.74	60.59	24.24	7.07	12.12	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	67.62	51.10	54.17	31.50	34.58	11.33	1.73	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	123.97	55.96	65.68	51.53	82.36	31.04	1.27	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	81.92	45.71	58.29	56.50	49.05	25.94	2.05	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	97.96	50.31	76.43	63.13	46.68	29.03	1.69	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	99.57	50.70	74.93	56.81	48.05	27.08	1.83	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	100.70	66.84	71.26	78.62	44.17	27.09	2.36	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	198.86	98.78	107.64	69.07	68.81	30.49	1.30	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	48.69	23.32	27.43	27.43	18.52	18.74	2.74	0.00
clear cell carcinoma cell line:TEN	10636-108I6	43.72	32.62	52.57	30.71	13.36	9.72	1.21	0.00
colon carcinoma cell line:CACO-2	10513-107D9	57.29	47.96	79.99	33.86	8.24	3.84	0.92	0.00
colon carcinoma cell line:COLO-320	10420-106C6	124.67	51.69	117.07	115.92	64.61	47.89	0.38	0.00
colon, adult, donor1	10082-102B1	71.40	53.55	24.99	11.90	8.33	11.90	0.00	0.00
colon, adult, pool1	10014-101C5	64.74	62.75	22.09	16.92	15.51	9.87	0.24	0.00
colon, fetal, donor1	10070-101I7	65.51	35.84	32.75	25.96	23.48	14.83	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	174.17	270.43	174.17	132.92	265.84	55.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	0.00	25.04	25.04	75.11	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	70.54	31.87	69.26	59.92	28.47	24.65	0.42	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	49.20	25.05	72.90	47.24	20.53	17.21	0.60	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	60.21	31.45	80.80	63.31	22.84	18.47	0.56	0.00
corpus callosum, adult, pool1	10042-101F6	115.43	93.65	14.93	16.25	12.83	9.18	0.44	0.00
cruciate ligament, donor2	10295-104G7	58.35	42.95	24.31	21.07	15.40	9.73	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	71.43	29.69	23.27	8.83	8.83	5.62	1.61	0.00
diencephalon, adult	10193-103E4	90.72	70.08	7.68	8.40	11.76	5.52	1.20	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	62.91	32.60	85.19	39.26	42.25	21.81	4.59	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	97.19	70.52	63.85	64.11	35.13	20.26	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	49.35	57.77	29.37	37.55	25.76	8.67	1.69	0.00
ductus deferens, adult	10196-103E7	80.23	64.29	17.44	9.47	8.47	4.49	1.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	89.29	54.73	36.01	24.48	12.96	15.84	2.88	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	96.37	75.04	44.14	18.39	16.18	11.03	2.21	0.00
dura mater, adult, donor1	10041-101F5	72.10	51.62	20.98	18.75	22.46	11.40	0.08	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	69.06	44.86	35.09	55.30	100.15	13.32	1.78	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	102.60	56.89	62.62	70.07	38.40	14.76	1.15	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	33.30	17.27	20.96	20.96	13.57	6.78	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	37.54	23.31	20.28	25.43	7.87	6.36	0.91	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	41.99	21.92	17.91	20.69	9.57	6.17	0.62	0.00
embryonic pancreas cell line:2C6	10603-108E9	48.60	32.84	32.84	21.02	19.70	15.76	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	41.56	22.12	40.22	29.50	6.03	4.02	0.67	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	88.62	46.58	38.97	25.55	7.25	7.25	1.45	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	50.17	47.92	28.46	16.24	5.79	5.63	1.13	0.00
epidermoid carcinoma cell line:A431	10426-106D3	51.13	58.80	39.79	49.91	73.92	22.79	0.44	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	66.54	73.69	103.17	72.04	30.91	16.50	0.55	0.00
epididymis, adult	10197-103E8	79.33	51.70	15.70	17.37	10.67	9.42	0.63	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	96.87	55.71	22.00	18.98	9.23	7.27	2.31	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	56.63	21.63	25.17	29.10	13.37	9.04	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	119.78	114.80	95.93	57.66	13.63	12.84	4.59	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	112.69	86.71	68.99	46.26	13.98	10.14	2.36	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	122.78	120.77	102.17	61.84	15.12	12.44	2.80	0.00
esophagus, adult, pool1	10015-101C6	47.14	46.93	17.52	12.21	13.38	8.71	0.21	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	71.63	40.70	48.84	52.35	28.93	13.90	0.75	0.00
eye - muscle inferior rectus, donor1	10272-104E2	43.46	67.61	19.32	2.41	4.83	7.24	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	82.06	42.08	8.42	8.42	8.42	4.21	0.00	0.00
eye - muscle medial, donor2	10299-104H2	61.02	44.65	5.95	8.93	8.93	8.93	0.00	0.00
eye - muscle superior, donor2	10297-104G9	77.96	41.27	14.90	20.64	12.61	13.76	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	45.18	20.40	14.57	14.57	13.12	5.83	0.00	0.00
eye, fetal, donor1	10054-101G9	83.39	44.24	20.08	13.47	9.41	11.19	1.02	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	58.60	28.59	28.85	20.64	14.87	14.23	0.13	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	151.71	93.78	89.98	58.88	29.44	16.38	3.80	0.00
frontal lobe, adult, pool1	10040-101F4	140.64	61.17	9.85	10.23	8.35	11.63	0.56	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	89.17	103.89	62.15	59.45	17.71	11.11	3.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	53.95	40.78	23.32	26.79	15.45	11.98	0.37	0.00
gall bladder, adult	10198-103E9	56.50	54.08	16.66	12.55	10.86	7.97	0.48	0.00
gamma delta positive T cells, donor1	11937-126A2	55.30	44.02	68.18	17.72	10.74	10.20	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	47.06	46.69	45.19	10.46	7.10	5.98	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	74.77	96.53	27.46	20.70	15.21	5.49	1.48	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	55.70	54.35	67.89	55.51	14.31	20.70	1.55	0.00
gastric cancer cell line:AZ521	10549-107H9	114.77	68.86	73.29	38.53	17.71	11.31	0.66	0.00
gastric cancer cell line:GSS	10560-108A2	90.61	41.19	117.15	90.61	25.63	40.27	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	65.11	67.62	51.40	34.04	16.45	9.82	2.74	0.00
giant cell carcinoma cell line:LU65	10487-107B1	40.62	18.82	37.18	20.54	4.36	3.67	1.03	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	93.63	57.66	65.78	50.81	42.97	20.29	0.28	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	58.61	48.64	39.16	18.21	9.98	4.99	1.25	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	90.14	91.30	69.98	41.17	16.78	11.72	1.37	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	93.11	88.76	73.87	41.71	15.45	9.69	1.83	0.00
glioblastoma cell line:T98G	10485-107A8	82.56	55.85	43.38	35.21	25.83	13.47	0.88	0.00
glioma cell line:GI-1	10413-106B8	55.35	50.37	34.85	24.60	15.82	4.10	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	86.01	65.60	14.58	16.04	10.20	11.66	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	111.80	85.68	19.53	13.67	11.23	8.06	1.46	0.00
globus pallidus, adult, donor10258	10367-105F7	99.95	72.57	2.74	2.74	8.22	4.11	2.74	0.00
globus pallidus, newborn, donor10223	10364-105F4	82.07	56.49	35.17	20.78	20.25	10.13	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	205.56	276.53	185.98	166.41	393.99	34.26	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	21.86	43.71	32.79	43.71	21.86	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	57.49	41.81	15.68	5.23	10.45	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	54.40	48.64	22.72	14.72	9.92	5.12	2.24	0.00
hIPS +CCl2, biol_rep1	14383-156B9	67.03	52.80	85.85	67.03	21.58	17.45	3.21	0.00
hIPS +CCl2, biol_rep2	14384-156C1	77.73	48.93	120.72	57.16	21.49	15.09	5.03	0.00
hIPS +CCl2, biol_rep3	14385-156C2	72.78	50.88	128.17	56.04	25.12	16.75	1.29	0.00
hIPS, biol_rep1	14380-156B6	48.87	79.05	135.11	23.00	24.43	11.50	0.00	0.00
hIPS, biol_rep2	14381-156B7	67.90	45.27	105.62	43.90	22.63	16.46	2.74	0.00
hIPS, biol_rep3	14382-156B8	97.11	81.66	16.55	17.66	5.52	6.62	3.31	0.00
hairy cell leukemia cell line:Mo	10712-109I1	63.50	28.45	49.14	30.46	26.15	17.82	0.86	0.00
heart - mitral valve, adult	10205-103F7	65.47	48.13	17.94	15.25	9.27	8.67	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	82.10	65.11	10.98	9.41	8.63	7.84	1.57	0.00
heart - tricuspid valve, adult	10207-103F9	49.96	41.63	69.94	35.80	20.82	14.99	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	51.01	31.83	7.35	5.51	3.67	1.84	2.04	0.00
heart, adult, diseased, donor1	10051-101G6	50.25	48.54	5.54	5.54	3.83	2.55	0.43	0.00
heart, adult, pool1	10016-101C7	62.09	75.43	16.10	12.65	8.28	8.51	0.23	0.00
heart, fetal, pool1	10046-101G1	86.15	63.05	22.38	21.36	15.71	12.12	0.92	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	50.60	45.97	20.36	11.11	6.79	3.09	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	39.24	48.76	21.41	30.92	47.57	5.95	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	93.26	77.68	64.20	53.37	28.84	15.36	2.98	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	100.62	85.69	67.97	64.21	29.13	13.96	1.94	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	99.84	88.52	76.60	63.76	31.83	15.16	1.52	0.00
hepatoma cell line:Li-7	10484-107A7	62.95	87.64	23.24	28.69	14.57	9.56	1.00	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	79.80	35.28	53.57	35.28	42.61	11.26	0.80	0.00
hippocampus - adult, donor10196	10169-103B7	93.69	54.89	17.98	17.03	10.41	10.41	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	115.11	75.31	19.59	12.65	11.63	8.98	1.22	0.00
hippocampus, adult, donor10258	10374-105G5	101.08	90.63	10.46	7.47	10.46	8.96	2.49	0.00
hippocampus, newborn, donor10223	10363-105F3	126.89	47.94	27.85	17.27	10.57	9.52	0.70	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	86.06	57.37	125.73	89.11	22.58	24.41	7.32	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	73.63	34.17	75.79	60.08	19.44	11.78	2.75	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	73.38	34.78	70.58	59.41	23.36	15.23	1.52	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	81.20	34.40	65.41	73.30	36.09	13.53	1.69	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	84.69	30.99	68.17	67.39	38.22	14.46	16.78	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	96.04	35.30	87.31	78.20	44.79	16.32	2.28	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	98.68	43.21	61.60	56.64	57.81	18.69	3.50	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	112.45	46.96	61.40	71.09	61.61	25.64	2.59	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	120.95	50.05	57.56	65.48	61.31	19.19	0.83	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	93.06	63.93	51.62	67.96	54.94	21.55	1.66	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	95.79	54.80	54.16	62.36	56.41	18.64	2.09	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	113.79	65.31	68.00	71.37	53.86	27.61	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	63.22	32.08	66.19	60.40	16.74	10.95	2.19	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	55.52	40.29	75.66	51.59	9.83	8.84	9.83	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	54.11	36.66	106.48	79.42	33.16	26.18	4.36	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	117.60	39.90	85.34	84.57	45.05	17.37	1.72	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	118.18	38.81	72.82	75.88	37.07	16.13	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	83.96	38.48	76.96	75.96	47.48	15.49	4.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	93.07	24.30	42.58	58.78	39.75	13.19	1.51	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	90.03	29.56	50.47	58.66	33.19	15.92	3.18	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	99.61	30.07	53.25	53.56	33.83	16.60	2.19	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	77.24	42.30	32.33	49.15	31.35	13.06	1.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	70.55	38.32	33.68	41.80	24.97	16.55	3.48	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	87.58	47.53	36.17	34.08	34.38	13.45	2.69	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	69.65	41.57	72.42	68.36	27.53	14.78	3.33	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	65.04	41.94	72.18	64.19	22.82	10.56	1.71	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	73.50	51.86	90.24	91.87	30.62	15.92	5.72	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	92.95	44.01	55.28	61.26	29.93	14.79	2.11	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	89.64	39.91	62.08	53.85	30.72	13.62	1.90	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	93.51	48.72	52.35	61.73	32.68	13.92	2.42	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	89.46	42.40	41.89	58.95	31.54	22.24	4.65	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	90.33	53.13	58.45	56.45	43.17	15.28	1.33	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	73.37	45.15	31.55	41.05	44.12	17.70	1.80	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	57.78	45.51	36.81	49.08	29.40	16.87	4.09	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	137.81	69.66	50.73	58.31	51.49	23.47	2.27	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	70.91	48.06	44.02	44.70	32.60	19.16	3.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	63.03	47.09	76.32	64.72	21.01	12.80	3.38	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	58.38	44.12	89.13	64.17	30.75	16.04	4.01	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	69.76	47.81	80.98	74.15	21.95	13.17	5.85	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	90.16	39.73	71.51	76.40	36.98	11.92	2.14	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	240.74	201.70	354.60	273.27	208.21	100.85	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	89.02	44.02	96.30	91.67	45.01	26.48	4.30	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	95.78	42.69	62.39	73.89	43.78	21.89	3.28	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	89.39	37.64	62.24	44.15	47.41	15.92	2.53	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	90.04	36.65	43.42	53.02	38.43	17.79	1.78	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	88.31	53.70	50.12	62.06	41.77	14.32	7.16	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	89.52	62.97	54.85	79.77	62.97	23.83	1.35	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	70.31	46.07	37.45	44.45	46.34	16.43	2.42	0.00
immature langerhans cells, donor1	11904-125F5	36.32	63.93	17.92	20.34	57.87	9.69	0.48	0.24
immature langerhans cells, donor2	11905-125F6	32.48	43.57	11.09	11.88	16.63	4.75	0.00	0.00
insula, adult, pool1	10039-101F3	155.48	68.70	10.69	12.02	10.32	11.26	0.38	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	30.24	29.26	14.96	8.78	6.18	0.98	0.33	0.00
kidney, adult, pool1	10017-101C8	64.08	53.77	19.83	13.42	8.51	9.31	0.80	0.00
kidney, fetal, pool1	10045-101F9	76.61	51.71	44.56	25.61	17.05	12.24	0.35	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	89.05	70.58	96.15	51.41	25.42	10.23	0.99	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	27.23	19.91	15.90	19.49	8.16	4.15	1.24	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	30.28	21.65	17.80	17.98	21.65	6.97	0.92	0.00
left atrium, adult, donor1	10079-102A7	54.49	42.50	8.72	9.26	5.99	4.90	1.09	0.00
left ventricle, adult, donor1	10078-102A6	47.03	39.95	12.64	9.10	3.03	6.07	1.01	0.00
leiomyoblastoma cell line:G-402	10721-110A1	64.02	81.26	75.79	38.58	10.94	8.76	0.55	0.00
leiomyoma cell line:10964C	10569-108B2	38.80	34.13	14.01	9.34	7.54	6.11	0.72	0.00
leiomyoma cell line:15242A	10570-108B3	38.59	33.15	20.65	8.15	5.98	3.26	0.00	0.00
leiomyoma cell line:15425	10571-108B4	46.86	42.74	24.52	12.38	8.01	4.37	2.67	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	44.45	82.54	19.05	6.35	0.00	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	49.14	57.51	26.14	12.55	7.32	2.09	2.09	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	43.80	34.35	63.52	43.68	56.90	13.69	1.18	0.00
liposarcoma cell line:KMLS-1	10782-110G8	53.58	55.61	15.78	10.62	3.91	1.41	0.78	0.00
liposarcoma cell line:SW 872	10726-110A6	96.74	78.59	30.58	29.24	18.89	12.06	0.61	0.00
liver, adult, pool1	10018-101C9	43.43	37.11	14.75	12.80	5.19	6.00	0.65	0.00
liver, fetal, pool1	10086-102B5	30.10	15.05	13.17	8.47	9.41	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	85.89	47.39	10.65	12.98	16.19	8.90	0.44	0.00
locus coeruleus, adult, donor10252	10165-103B3	76.77	54.26	16.06	12.55	11.07	9.23	1.29	0.00
locus coeruleus, adult, donor10258	10375-105G6	79.56	38.94	6.77	9.03	6.77	4.51	0.85	0.00
locus coeruleus, newborn, donor10223	10362-105F2	68.56	56.36	50.89	26.50	16.40	14.30	2.10	0.00
lung adenocarcinoma cell line:A549	10499-107C4	50.79	28.92	20.21	13.29	7.06	4.84	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	67.56	71.70	84.80	35.16	19.99	10.34	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	39.94	28.60	30.45	31.24	28.47	10.55	0.53	0.00
lung, adult, pool1	10019-101D1	60.84	37.21	23.98	18.07	14.65	11.58	0.83	0.00
lung, fetal, donor1	10068-101I5	95.04	72.49	61.36	47.38	26.54	26.54	1.14	0.00
lung, right lower lobe, adult, donor1	10075-102A3	68.73	38.49	19.25	8.25	9.16	9.62	2.75	0.00
lymph node, adult, donor1	10077-102A5	54.44	27.46	28.88	17.51	14.67	11.83	3.31	0.00
lymphangiectasia cell line:DS-1	10727-110A7	61.81	38.79	39.89	28.05	28.71	10.96	0.22	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	81.80	51.62	97.05	27.17	10.72	4.98	1.66	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	49.27	55.22	37.38	46.72	54.37	11.04	0.00	0.00
mature adipocyte, donor1	12231-129F8	88.35	120.32	5.77	9.32	11.10	6.66	0.00	0.00
mature adipocyte, donor2	12232-129F9	72.01	92.77	7.26	9.96	6.64	5.60	0.00	0.00
mature adipocyte, donor3	12233-129G1	74.67	73.02	9.96	10.19	8.77	5.93	0.24	0.00
mature adipocyte, donor4	12234-129G2	93.18	105.02	6.32	9.74	14.21	7.63	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	81.96	42.17	72.43	66.71	21.68	19.54	1.19	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	148.90	62.04	10.15	11.28	12.41	14.66	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	116.41	63.63	11.95	12.51	9.20	7.36	0.74	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	101.66	49.56	5.40	7.62	9.53	6.35	1.27	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	92.55	49.47	25.59	20.47	20.47	17.06	1.28	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	121.67	49.28	9.96	10.46	15.02	9.28	12.66	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	126.27	77.04	13.79	13.37	10.40	9.55	1.91	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	71.27	90.53	13.48	0.00	21.19	11.56	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	272.72	401.90	28.71	28.71	57.41	43.06	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	94.76	35.89	20.10	22.61	12.56	7.90	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	64.25	58.41	13.63	12.33	14.28	14.28	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	89.01	63.62	19.04	14.71	9.44	7.12	1.39	0.00
medulla oblongata, adult, pool1	10038-101F2	89.87	67.91	15.35	12.41	12.57	9.71	0.57	0.00
medulla oblongata, newborn, donor10223	10361-105F1	69.09	49.65	31.59	21.18	9.37	8.33	1.04	0.00
medulloblastoma cell line:D283 Med	10838-111E1	123.33	150.12	79.71	74.84	49.82	13.51	3.54	0.22
medulloblastoma cell line:ONS-76	10759-110E3	89.75	60.04	36.80	43.28	39.98	18.59	0.24	0.00
melanoma cell line:COLO 679	10514-107E1	61.95	47.58	19.41	29.61	40.39	13.37	0.14	0.00
melanoma cell line:G-361	10465-106H6	60.81	27.69	24.70	38.28	47.23	26.06	1.36	0.00
meningioma cell line:HKBMM	10691-109F7	40.70	23.88	15.38	18.81	15.20	7.78	2.53	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	157.73	90.76	53.75	58.16	35.25	19.39	2.64	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	152.68	102.13	97.99	75.17	24.63	17.11	1.56	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	57.38	53.09	33.76	22.25	8.75	6.75	2.30	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	39.99	36.54	14.91	12.36	9.45	4.36	0.36	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	44.31	61.29	28.99	18.63	4.97	5.38	1.24	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	51.13	51.55	18.40	9.13	3.37	2.25	0.56	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	44.48	52.38	18.10	8.67	4.81	3.47	0.39	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	64.55	69.41	28.46	13.88	4.16	1.39	2.78	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	31.58	24.72	14.07	6.35	4.29	2.40	0.86	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	37.96	44.86	25.42	10.81	4.26	2.99	1.27	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	50.80	45.49	25.07	13.79	4.64	4.11	0.93	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	58.47	45.64	28.36	20.26	8.37	4.46	0.27	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	48.65	34.85	40.26	20.49	5.55	5.41	1.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	47.10	30.30	14.82	6.92	5.60	3.95	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	54.93	39.44	26.43	15.36	5.40	4.15	0.28	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	52.36	54.46	27.58	15.01	9.77	8.38	2.09	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	32.46	32.46	17.15	11.43	7.76	4.90	0.41	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	43.49	34.51	30.55	12.22	6.11	3.24	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	33.83	22.55	14.38	8.79	2.79	3.31	0.31	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	28.04	41.95	21.66	11.17	5.47	1.14	0.68	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	81.39	80.97	62.51	42.38	13.85	12.17	2.10	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	47.22	37.06	19.28	12.85	4.33	5.08	0.45	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	42.98	27.83	19.96	9.72	4.38	2.45	0.53	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	47.49	35.34	20.62	8.10	4.79	3.31	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	37.49	45.79	30.05	19.17	6.87	5.44	1.14	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	88.83	66.10	43.36	25.68	16.84	10.53	5.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	58.00	52.52	16.44	4.11	4.57	2.74	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	55.76	61.90	17.90	7.42	5.37	3.84	1.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	69.37	59.94	16.49	9.16	3.66	2.09	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	63.77	55.76	23.11	8.32	6.78	2.46	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	54.13	57.66	17.42	8.94	4.71	2.59	2.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	62.61	63.63	22.00	11.51	5.08	3.72	2.03	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	62.48	53.84	16.90	9.82	4.32	4.32	1.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	64.41	65.80	23.17	7.88	6.02	5.10	0.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	48.30	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	69.22	69.51	21.05	8.65	4.90	5.77	2.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	67.60	62.69	20.08	9.15	5.35	2.68	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	63.69	58.17	19.95	10.58	4.81	2.16	0.96	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	79.20	92.40	22.00	8.80	3.67	5.13	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	61.76	57.73	14.43	11.08	3.69	4.36	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	62.63	67.55	16.38	9.83	2.87	2.46	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	66.58	58.85	22.34	8.59	6.44	2.58	1.72	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	101.17	95.70	16.41	19.14	10.94	8.20	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	82.64	103.30	41.32	0.00	5.16	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	68.53	73.73	22.74	11.69	7.79	4.22	2.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	90.21	74.20	30.55	10.18	10.18	5.82	2.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	82.63	66.63	18.12	11.73	3.73	5.86	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	64.60	64.60	26.17	7.36	6.54	4.09	2.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	71.52	65.69	24.88	10.88	6.22	3.89	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	71.36	83.95	27.28	6.30	0.00	4.20	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	73.52	63.58	20.86	5.96	3.97	6.95	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	85.81	61.97	28.60	14.30	4.77	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	76.49	59.30	26.68	10.67	6.52	2.96	1.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	87.73	70.67	25.59	14.62	7.31	4.87	2.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	27.05	54.10	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	77.27	74.74	18.37	5.07	7.60	5.70	3.17	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	75.88	60.01	16.21	6.55	6.90	4.14	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	64.48	70.92	25.79	8.60	15.04	0.00	6.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	43.91	39.92	19.96	3.99	0.00	3.99	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	44.77	44.77	34.44	6.89	0.00	0.00	6.89	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	47.67	46.04	17.11	5.30	4.48	2.85	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	42.11	39.72	18.27	3.18	0.79	2.38	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	48.93	38.91	18.28	4.72	1.18	1.77	1.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	40.52	50.81	15.59	8.42	4.05	4.05	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	56.14	52.13	17.38	5.35	1.34	4.01	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	48.49	82.79	22.47	9.46	10.64	2.37	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	46.22	115.56	23.11	2.57	7.70	0.00	7.70	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	59.20	96.38	15.14	4.82	11.01	3.44	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	56.90	105.89	11.88	2.97	0.49	0.99	1.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	48.22	97.57	11.22	3.36	10.09	1.12	2.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	59.79	95.41	8.90	6.36	3.18	1.91	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	59.64	81.40	20.96	7.66	4.03	1.21	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	69.78	74.14	19.63	0.00	6.54	8.72	4.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	43.08	62.09	7.60	6.34	3.80	2.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	53.41	53.41	7.89	8.50	3.64	3.03	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	49.71	49.71	27.11	9.04	9.04	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	42.01	43.66	7.41	4.12	9.06	4.94	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	46.83	73.22	20.64	9.52	4.37	3.17	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	50.95	63.60	14.60	9.41	3.89	4.54	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	63.15	75.38	19.35	7.13	4.07	5.09	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	71.96	114.51	28.63	20.12	10.83	4.64	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	54.10	30.71	36.85	48.90	13.47	11.81	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	55.83	47.96	47.26	50.74	29.89	17.84	0.23	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	68.38	128.21	21.37	12.82	34.19	8.55	12.82	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	46.96	56.82	27.33	24.87	28.46	10.69	1.34	0.00
mesothelioma cell line:Mero-25	10850-111F4	25.19	17.25	15.21	21.11	14.53	4.99	0.68	0.00
mesothelioma cell line:Mero-41	10851-111F5	101.21	61.61	62.83	47.18	19.56	18.82	1.47	0.00
mesothelioma cell line:Mero-48a	10852-111F6	73.52	65.76	31.89	23.91	12.84	10.63	2.44	0.00
mesothelioma cell line:Mero-82	10853-111F7	62.55	59.13	28.91	28.38	37.32	13.67	1.31	0.00
mesothelioma cell line:Mero-83	10854-111F8	54.13	67.07	39.49	26.72	10.55	6.30	1.02	0.00
mesothelioma cell line:Mero-84	10855-111F9	25.53	23.26	20.98	13.14	4.30	4.80	1.52	0.00
mesothelioma cell line:Mero-95	10856-111G1	47.00	43.27	34.58	24.64	20.91	14.08	0.83	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	75.20	74.87	49.36	39.09	27.33	14.74	1.82	0.00
mesothelioma cell line:NCI-H226	10846-111E9	49.59	47.96	29.86	32.58	21.90	8.33	1.27	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	82.51	53.30	59.96	30.92	15.20	11.10	1.20	0.00
mesothelioma cell line:NCI-H28	10845-111E8	52.93	39.70	47.59	22.14	10.94	6.62	0.76	0.00
mesothelioma cell line:No36	10857-111G2	42.41	48.28	12.07	13.05	4.24	4.89	0.98	0.00
mesothelioma cell line:ONE58	10858-111G3	60.42	55.27	58.80	36.58	11.65	10.03	1.08	0.00
migratory langerhans cells, donor1	11901-125F2	68.90	52.59	58.73	27.06	15.16	9.40	0.58	0.00
migratory langerhans cells, donor2	11902-125F3	60.20	44.08	43.23	17.71	10.26	7.94	0.49	0.00
migratory langerhans cells, donor3	11903-125F4	77.54	51.51	34.82	14.54	16.69	10.95	0.18	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	87.17	39.50	17.63	22.85	16.32	3.59	4.24	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	46.20	15.26	19.50	15.47	12.93	5.51	0.64	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	59.43	46.99	33.63	23.04	32.71	11.98	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	36.73	23.03	45.29	27.78	15.98	15.03	0.95	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	107.92	68.74	63.57	43.80	38.07	13.67	0.74	0.00
myeloma cell line:PCM6	10474-106I6	55.74	28.46	17.99	12.26	7.31	6.52	0.40	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	44.13	74.06	21.31	21.81	26.89	11.67	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	61.59	56.49	10.00	6.86	8.04	3.92	0.59	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	29.30	17.72	11.70	11.48	7.13	4.46	0.22	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	30.23	19.49	12.80	12.80	9.85	4.19	0.22	0.00
nasal epithelial cells, donor2	12227-129F4	27.05	24.84	13.80	28.15	19.32	5.52	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	119.63	86.27	93.17	95.25	81.90	39.34	0.92	0.00
neuroblastoma cell line:NB-1	10539-107G8	112.25	100.09	98.59	55.38	41.16	22.82	0.94	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	84.57	132.02	70.65	82.25	29.74	16.87	2.53	0.00
neuroblastoma cell line:NH-12	10555-107I6	96.53	87.03	83.86	98.21	82.37	36.15	0.93	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	145.42	221.57	86.11	79.47	63.34	19.45	6.41	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	140.17	368.39	85.37	117.68	53.06	17.90	5.54	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	84.53	109.28	50.31	45.28	24.96	10.06	1.81	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	139.23	185.01	93.46	75.02	33.70	17.80	2.54	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	65.48	52.97	26.88	12.24	12.78	6.12	0.27	0.00
neutrophil PMN, donor1	12133-128D9	29.75	163.62	0.00	44.62	59.50	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	53.12	13.28	13.28	13.28	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	66.29	28.41	0.00	18.94	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	196.18	48.03	118.89	131.07	345.34	54.80	1.86	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	48.03	51.23	21.61	43.23	28.02	22.41	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	49.69	52.58	15.71	13.47	3.85	4.49	2.24	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	61.49	53.60	23.12	15.24	14.71	8.93	2.89	0.00
nucleus accumbens, adult, pool1	10037-101F1	136.02	69.46	12.75	12.00	7.41	8.16	0.28	0.00
occipital cortex - adult, donor10196	10172-103C1	142.17	72.11	14.42	12.36	4.12	14.42	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	127.20	67.63	14.76	14.22	11.81	7.25	2.42	0.00
occipital cortex, newborn, donor10223	10355-105E4	123.74	38.21	27.30	23.66	20.74	12.37	0.73	0.00
occipital lobe, adult, donor1	10076-102A4	175.02	64.81	12.07	10.76	10.50	10.50	2.36	0.26
occipital lobe, fetal, donor1	10073-102A1	253.17	72.52	102.98	63.51	41.62	32.18	5.15	0.00
occipital pole, adult, pool1	10036-101E9	108.80	50.62	7.02	9.15	5.91	7.49	0.16	0.00
olfactory region, adult	10195-103E6	109.28	57.51	8.22	9.36	9.17	8.79	0.38	0.00
optic nerve, donor1	10277-104E7	168.09	86.05	10.01	12.01	12.01	14.01	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	48.64	36.79	49.21	28.82	5.24	4.10	0.23	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	43.41	45.47	60.18	41.22	14.43	10.72	0.27	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	90.59	77.55	66.21	38.27	18.12	8.30	3.73	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	40.66	24.14	48.05	25.18	12.36	6.12	0.92	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	92.89	72.61	13.23	6.17	2.65	3.53	0.88	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	52.32	51.39	46.72	100.91	117.73	43.91	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	28.84	34.99	14.63	14.00	12.51	5.51	0.42	0.00
ovary, adult, pool1	10020-101D2	73.03	49.44	28.56	26.21	21.49	17.03	0.44	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	81.39	51.33	33.91	24.56	17.42	6.97	1.10	0.00
pancreas, adult, donor1	10049-101G4	76.19	29.16	15.99	10.35	11.29	6.58	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	33.54	23.48	29.63	31.59	14.26	7.55	0.56	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	73.76	59.28	44.80	31.17	18.06	6.30	2.38	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	52.99	39.24	46.20	39.41	28.81	18.05	0.33	0.00
paracentral gyrus, adult, pool1	10035-101E8	129.69	60.50	9.52	11.62	8.88	8.42	0.73	0.00
parietal cortex, adult, donor10258	10373-105G4	111.57	57.99	11.74	18.35	8.81	6.61	2.20	0.00
parietal lobe - adult, donor10196	10171-103B9	94.99	52.67	9.40	9.40	3.76	6.58	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	121.43	60.71	13.97	10.83	10.83	9.98	2.28	0.29
parietal lobe, adult, pool1	10034-101E7	130.95	61.68	9.16	9.61	8.64	7.31	0.70	0.00
parietal lobe, fetal, donor1	10072-101I9	208.51	91.16	124.14	72.74	45.58	28.13	12.61	0.00
parietal lobe, newborn, donor10223	10356-105E5	98.33	37.01	35.14	20.94	15.70	14.58	0.37	0.00
parotid gland, adult	10199-103F1	87.57	52.42	9.25	4.32	9.25	10.48	0.62	0.00
penis, adult	10200-103F2	60.16	48.34	12.89	12.35	9.13	9.13	1.61	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	40.53	48.72	17.29	43.51	24.92	17.66	2.23	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	284.69	193.92	155.89	92.22	51.58	43.27	4.52	0.15
pineal gland - adult, donor10196	10179-103C8	114.81	74.82	12.26	16.13	13.55	18.06	1.29	0.00
pineal gland, adult, donor10252	10160-103A7	148.65	131.47	28.43	18.36	14.21	13.62	2.37	0.00
pineal gland, adult, donor10258	10377-105G8	147.99	64.59	20.69	15.68	8.78	7.52	1.88	0.00
pituitary gland - adult, donor10196	10180-103C9	131.53	73.86	34.40	18.21	11.13	14.17	3.04	0.00
pituitary gland, adult, donor10252	10162-103A9	153.75	103.19	69.84	20.85	11.47	11.47	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	125.98	79.17	45.97	32.35	22.13	15.32	0.85	0.00
placenta, adult, pool1	10021-101D3	66.11	59.13	21.50	20.43	10.97	9.35	0.32	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	41.58	18.67	59.19	37.34	17.08	10.73	0.93	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	36.26	31.75	23.81	17.43	21.63	5.14	0.47	0.00
pons, adult, pool1	10033-101E6	86.50	55.51	9.98	11.62	10.33	6.46	0.52	0.00
postcentral gyrus, adult, pool1	10032-101E5	115.25	54.75	7.50	9.85	8.28	9.33	0.52	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	121.30	292.80	71.11	89.93	217.51	29.28	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	60.59	44.06	11.02	11.02	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	35.21	23.47	11.74	35.21	11.74	11.74	0.00
prostate cancer cell line:DU145	10490-107B4	45.59	32.05	46.17	23.16	5.39	2.91	1.46	0.00
prostate cancer cell line:PC-3	10439-106E7	90.39	68.97	39.20	33.40	10.71	8.17	1.45	0.00
prostate, adult, pool1	10022-101D4	62.12	48.70	25.85	15.42	11.61	11.61	0.45	0.00
putamen, adult, donor10196	10176-103C5	160.76	59.25	17.00	11.09	7.79	11.80	1.42	0.00
putamen, adult, donor10252	10152-102I8	133.33	64.70	23.53	13.73	19.61	9.80	3.92	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	93.98	102.72	46.99	15.30	19.67	8.74	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	125.40	55.81	10.63	9.91	5.80	9.18	0.24	0.00
putamen, newborn, donor10223	10365-105F5	87.71	48.73	69.72	41.98	19.49	12.74	3.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	27.35	24.44	45.39	39.57	26.77	12.22	0.58	0.00
rectum, fetal, donor1	10067-101I4	127.97	54.25	63.99	44.51	50.08	26.43	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	48.76	30.74	41.76	19.29	7.21	6.78	0.42	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	26.92	4.97	16.15	42.25	24.85	14.08	2.90	0.00
retina, adult, pool1	10030-101E3	80.91	59.24	14.71	13.22	9.34	8.25	0.60	0.00
retinoblastoma cell line:Y79	10475-106I7	121.07	73.78	68.07	75.60	71.97	30.92	3.64	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	66.76	37.75	32.95	27.66	16.72	10.20	0.25	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	167.31	118.95	129.07	106.29	71.42	30.09	3.37	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	75.03	59.87	22.74	12.88	14.40	6.82	0.00	0.00
salivary acinar cells, donor1	11771-123I7	43.38	45.64	23.95	29.94	14.41	7.12	0.81	0.00
salivary acinar cells, donor2	11772-123I8	40.62	52.32	28.23	19.83	14.73	6.88	1.24	0.00
salivary acinar cells, donor3	11773-123I9	30.45	55.61	21.19	21.19	19.20	9.93	0.00	0.00
salivary gland, adult, pool1	10093-102C3	57.20	47.47	18.30	10.87	16.01	8.01	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	82.88	32.88	33.39	31.79	14.33	16.10	1.10	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	71.35	31.15	24.92	25.98	9.76	12.11	0.94	0.00
seminal vesicle, adult	10201-103F3	99.47	59.79	22.75	12.70	16.40	7.41	3.17	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	57.57	54.17	43.24	23.56	16.76	7.29	1.70	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	46.80	49.57	31.96	15.35	5.54	6.54	1.01	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	74.26	57.20	54.19	30.11	10.04	11.04	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	65.15	95.10	76.83	73.20	16.39	11.82	1.61	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	47.20	34.82	29.62	25.53	13.04	7.18	0.11	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	62.19	73.42	79.22	51.87	24.77	16.13	1.03	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	92.92	28.37	5.67	2.84	5.67	0.71	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	72.80	37.30	8.88	9.36	5.76	4.20	0.24	0.00
skeletal muscle, fetal, donor1	10066-101I3	74.37	42.21	27.14	24.12	29.15	7.04	1.01	0.00
skin, adult, donor1	10074-102A2	74.64	61.07	27.14	27.14	20.36	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	89.63	59.97	35.35	21.46	19.57	14.52	6.94	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	110.06	44.69	52.03	25.35	9.01	5.00	1.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	96.77	131.76	47.91	57.05	49.49	23.01	2.21	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	96.95	48.38	16.96	23.71	7.71	7.52	2.51	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	80.44	67.58	126.92	76.48	83.90	21.59	1.48	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	92.17	50.99	38.44	80.10	55.65	14.48	2.25	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	161.69	107.43	26.80	45.33	60.36	33.12	3.27	0.00
small intestine, adult, pool1	10024-101D6	67.84	78.24	26.87	17.44	16.36	9.79	0.84	0.00
small intestine, fetal, donor1	10064-101I1	68.55	45.21	35.87	23.34	19.16	12.28	2.21	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	41.03	36.42	25.13	26.67	22.05	5.13	3.08	0.00
smooth muscle, adult, pool1	10048-101G3	51.69	35.67	13.70	7.24	10.08	7.24	0.52	0.00
somatostatinoma cell line:QGP-1	10781-110G7	66.47	54.14	33.23	20.91	14.21	6.97	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	85.34	49.32	15.14	11.70	18.81	11.24	1.38	0.00
spinal cord, adult, donor10252	10159-103A6	65.45	70.57	19.32	12.22	13.80	8.67	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	69.18	101.00	19.37	8.99	15.91	13.84	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	101.84	48.79	27.44	21.95	20.12	14.64	1.22	0.00
spinal cord, newborn, donor10223	10359-105E8	65.67	69.80	34.44	26.18	24.80	9.18	2.30	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	70.50	55.56	22.40	12.84	9.86	7.32	0.45	0.00
spleen, adult, pool1	10025-101D7	62.01	34.14	40.86	23.46	15.20	11.89	0.44	0.00
spleen, fetal, pool1	10044-101F8	55.78	37.03	39.81	20.10	14.22	11.92	0.32	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	72.25	26.29	65.01	39.44	39.65	21.12	0.83	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	30.57	22.97	54.87	33.99	9.11	6.65	0.95	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	55.56	37.04	13.28	9.44	5.24	2.45	1.75	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	46.13	43.39	50.43	46.52	52.38	17.20	1.56	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	69.22	56.39	15.98	25.66	24.43	13.96	0.79	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	59.30	29.23	60.58	40.24	20.76	17.37	2.54	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	80.38	46.54	57.54	31.31	10.15	7.62	1.27	0.00
stomach, fetal, donor1	10062-101H8	83.30	53.40	16.02	27.77	40.58	21.36	0.00	0.00
submaxillary gland, adult	10202-103F4	72.92	50.70	19.94	9.11	8.55	6.84	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	108.55	54.27	0.00	54.27	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	79.55	69.37	16.62	9.14	9.97	6.02	3.12	0.00
substantia nigra, adult, donor10258	10371-105G2	72.93	80.17	11.38	8.28	16.03	8.79	1.55	0.00
substantia nigra, newborn, donor10223	10358-105E7	74.90	63.59	38.16	23.32	19.08	11.31	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	79.10	57.32	55.25	48.83	16.28	19.26	0.46	0.00
temporal lobe, adult, pool1	10031-101E4	105.12	50.10	9.32	10.09	6.95	7.21	0.34	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	171.66	61.25	57.69	37.04	39.17	18.52	5.70	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	156.48	61.97	53.62	39.56	32.53	18.02	3.08	0.00
tenocyte, donor1	11763-123H8	70.17	83.78	32.82	10.82	6.63	2.09	2.79	0.00
tenocyte, donor2	11765-123I1	50.36	52.65	16.40	10.68	7.63	4.20	2.67	0.00
tenocyte, donor3	11768-123I4	52.26	68.57	28.91	8.53	5.19	2.97	2.59	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	130.70	49.97	68.83	107.25	51.84	28.89	3.57	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	62.12	43.01	37.46	26.36	17.26	9.09	1.39	0.00
teratocarcinoma cell line:PA-1	10807-111A6	57.81	32.08	34.56	45.10	25.57	10.23	1.08	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	84.04	42.27	32.88	42.40	27.67	8.89	1.02	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	80.93	28.74	36.30	37.82	58.99	7.19	1.89	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	41.01	25.74	23.45	37.74	43.84	12.65	0.55	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	101.29	22.80	46.90	61.23	51.79	20.19	5.54	0.00
testis, adult, pool1	10026-101D8	245.78	53.36	33.71	68.93	16.75	25.23	2.04	3.97
testis, adult, pool2	10096-102C6	422.67	69.47	50.07	101.95	24.81	43.76	5.41	15.34
thalamus - adult, donor10196	10168-103B6	92.73	89.42	16.56	13.25	15.46	15.46	0.00	0.00
thalamus, adult, donor10252	10154-103A1	97.36	75.80	18.13	13.75	9.85	7.50	1.25	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	101.61	198.61	33.87	4.62	10.78	15.40	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	77.90	42.33	7.25	7.25	6.59	3.79	1.32	0.00
thalamus, newborn, donor10223	10366-105F6	64.44	54.08	26.46	17.83	13.23	5.75	1.73	0.00
throat, adult	10209-103G2	55.18	54.68	16.73	14.23	9.49	7.49	0.75	0.00
throat, fetal, donor1	10061-101H7	85.93	45.71	21.63	12.49	13.71	7.31	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	78.90	46.50	65.58	62.80	61.41	48.89	0.79	0.00
thymus, adult, pool1	10027-101D9	132.92	76.35	93.85	38.08	15.71	18.89	1.09	0.00
thymus, fetal, pool1	10043-101F7	115.23	68.37	71.38	27.22	15.48	13.61	1.04	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	71.40	47.87	28.45	25.93	26.06	10.77	2.26	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	60.21	42.89	32.83	42.05	55.32	22.21	0.84	0.00
thyroid, adult, pool1	10028-101E1	79.32	50.58	28.74	13.72	10.92	10.82	0.65	0.00
thyroid, fetal, donor1	10060-101H6	113.11	51.94	18.98	10.81	8.96	7.91	1.05	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	113.95	61.59	3.08	18.48	21.56	12.32	0.00	0.00
tongue, adult	10203-103F5	55.82	60.00	13.49	12.56	8.37	9.30	1.63	0.00
tongue, fetal, donor1	10059-101H5	74.09	47.29	16.95	9.85	7.88	7.49	0.39	0.00
tonsil, adult, pool1	10047-101G2	68.72	49.19	36.86	21.44	12.42	12.22	0.20	0.00
trachea, adult, pool1	10029-101E2	53.25	51.45	26.83	19.30	14.07	12.27	0.49	0.00
trachea, fetal, donor1	10058-101H4	78.09	46.55	29.62	18.47	23.85	13.85	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	60.58	51.37	37.91	23.38	13.82	8.15	1.06	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	80.65	46.30	86.42	68.08	32.62	10.94	0.51	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	55.00	27.26	58.29	37.13	15.20	11.28	1.25	0.00
tridermal teratoma cell line:HGRT	10694-109G1	38.05	57.08	9.51	24.73	30.44	17.12	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	35.47	33.94	32.00	19.30	7.62	4.66	0.59	0.00
umbilical cord, fetal, donor1	10057-101H3	47.99	22.95	8.35	6.26	6.26	8.35	0.00	0.00
uterus, adult, pool1	10100-102D1	73.88	68.42	31.22	24.74	18.26	15.87	0.17	0.00
uterus, fetal, donor1	10055-101H1	96.75	48.12	33.79	35.32	32.25	23.04	0.51	0.00
vagina, adult	10204-103F6	51.70	36.83	43.30	11.63	7.11	8.40	0.00	0.00
vein, adult	10191-103E2	64.44	32.44	32.44	14.91	12.71	7.89	1.10	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	43.26	22.97	35.52	18.96	20.83	12.02	1.34	0.00